hg_234520.1

Basic information about the TSS

---

TSS ID: hg_234520.1 Species: human Chr: chr1		Start: 26280048 End: 26280049 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: LF206661 MA442238 Distance: -23 GeneID: 10728 HGNC/MGI_ID: HGNC:16049 UniProt_ID:

Gene_name: PTGES3 Gene_symbol: PTGES3 Gene_synonyms: TEBP cPGES p23 Gene_source: HGNC:16049

TATA-Box annotation

---

Distance to TSS:	-132
Nearest PromoterID:	NR_104219
Entrez ID:	10728
Nearest Unigene:	Hs.50425
Nearest Refseq:	NM_006601
Nearest Ensembl:	ENSG00000110958
Gene Name:	PTGES3
Gene Alias:	P23|TEBP|cPGES
Gene Description:	prostaglandin E synthase 3
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.686567
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PTGES3 p2@PTGES3 p3@PTGES3 p4@PTGES3 p5@PTGES3 p7@PTGES3 p8@PTGES3 p9@PTGES3
Sample		p1@PTGES3	p2@PTGES3	p3@PTGES3	p4@PTGES3	p5@PTGES3	p7@PTGES3	p8@PTGES3	p9@PTGES3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	309.74	92.92	115.52	4.68	7.40	0.00	0.39	12.47
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	318.65	103.59	123.41	9.31	8.70	0.40	1.42	12.54
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	321.57	105.52	137.15	5.21	4.05	0.39	0.58	14.66
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	296.90	90.23	112.69	3.74	4.37	0.21	0.42	9.56
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	304.38	87.51	126.21	5.62	5.85	0.22	0.22	14.40
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	296.53	85.47	108.92	3.88	5.62	0.00	0.19	9.69
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	384.13	131.82	143.80	6.75	7.84	0.22	1.09	16.12
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	317.07	78.96	128.38	6.30	5.09	0.00	0.73	12.11
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	316.09	91.47	114.77	5.98	9.40	0.21	0.64	14.11
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	271.27	70.71	106.65	5.80	6.96	0.00	0.00	6.96
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	272.45	62.66	101.46	3.64	6.47	0.00	0.81	8.89
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	260.19	83.34	92.69	6.50	4.47	0.00	0.00	11.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	137.66	53.35	48.04	11.28	16.44	0.00	0.16	19.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	107.95	37.89	32.63	6.62	8.42	0.15	0.15	12.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	113.29	47.86	42.37	12.95	10.32	0.00	0.44	16.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	113.42	43.76	36.97	10.06	5.78	0.25	0.00	14.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	121.00	41.93	37.13	10.05	7.64	0.00	0.00	15.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	115.16	39.65	45.56	10.12	12.23	0.00	0.00	11.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	134.35	46.92	50.65	8.00	10.13	0.00	0.00	12.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	116.29	46.94	40.02	13.09	11.73	0.15	0.00	19.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	119.08	40.36	37.42	11.36	11.63	0.13	0.00	16.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	114.45	42.29	43.33	9.84	10.70	0.17	0.00	14.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	107.15	38.39	34.25	10.99	10.08	0.00	0.00	14.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	111.63	41.74	39.31	11.89	9.22	0.00	0.00	17.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	143.44	58.31	52.37	14.19	10.06	0.00	0.26	17.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	135.78	50.64	48.11	12.66	9.81	0.00	0.32	15.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	157.15	46.70	61.54	6.59	12.09	0.00	0.00	15.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	113.16	52.10	53.04	13.67	12.73	0.47	0.00	21.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	123.24	45.87	44.74	11.63	11.47	0.00	0.48	16.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	113.28	54.11	44.70	13.57	12.49	0.18	0.00	20.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	127.28	37.47	42.08	8.37	9.63	0.21	0.00	16.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	138.53	53.53	47.67	10.36	11.92	0.00	0.00	17.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	137.59	40.73	42.42	11.61	11.61	0.00	0.42	17.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	133.11	43.54	40.58	8.08	8.74	0.00	0.00	12.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	106.96	46.00	40.02	9.16	10.10	0.00	0.00	16.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	121.68	50.01	43.50	13.41	10.35	0.00	0.19	16.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	114.86	50.69	41.90	10.63	12.67	0.00	0.00	15.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	94.09	39.49	35.66	10.48	10.28	0.00	0.00	17.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	114.25	46.73	39.98	11.07	12.96	0.27	0.00	15.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	112.11	51.85	44.17	12.48	13.20	0.00	0.24	18.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	113.16	46.82	50.82	11.29	12.70	0.00	0.00	18.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	131.75	46.70	45.38	9.81	14.35	0.00	0.00	14.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	118.10	68.96	41.55	13.50	10.54	0.21	0.00	21.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	129.90	55.07	52.62	12.76	11.71	0.17	0.17	17.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	107.41	59.23	43.17	15.66	12.25	0.00	0.00	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	122.60	51.41	50.48	12.80	12.80	0.00	0.00	21.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	139.39	58.06	53.98	11.76	12.95	0.00	0.48	20.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	132.93	63.48	44.71	14.01	19.37	0.30	0.30	13.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	125.43	52.66	44.28	12.45	12.45	0.00	0.00	15.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	122.13	45.09	52.57	9.91	10.11	0.20	0.20	15.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	110.88	43.45	42.63	13.12	10.45	0.41	0.00	14.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	127.20	52.70	50.48	12.23	10.23	0.00	0.00	14.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	139.92	139.92	55.97	13.99	13.99	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	99.01	36.20	34.07	5.32	8.52	0.00	0.00	14.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	95.11	29.82	37.45	6.30	9.28	0.00	0.33	12.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	114.93	53.69	43.62	5.87	17.62	0.00	0.00	15.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	114.81	43.63	45.01	5.97	11.02	0.00	0.00	13.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	108.58	37.27	45.38	10.37	8.10	0.00	0.32	17.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	103.10	37.90	41.11	9.31	10.92	0.00	0.32	15.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	107.19	58.47	46.84	7.86	5.97	0.00	0.31	9.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	109.28	26.79	40.89	7.76	6.35	0.00	0.00	11.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	112.16	25.24	42.62	7.29	8.41	0.00	1.68	8.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	116.24	42.99	31.05	8.76	9.55	0.00	0.80	14.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	107.03	25.14	33.30	8.15	3.74	0.34	0.34	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	94.55	28.92	33.79	6.82	9.10	0.00	0.00	11.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	81.65	29.46	30.88	9.23	9.23	0.00	0.00	13.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	242.46	80.82	96.98	80.82	64.66	16.16	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	173.74	126.36	78.97	23.69	39.49	15.79	7.90	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	99.94	35.59	40.46	8.29	7.31	0.00	0.49	7.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	120.99	38.18	53.55	7.93	6.45	0.50	0.00	10.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	107.43	30.49	48.32	3.75	10.79	0.00	0.00	10.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	111.94	63.59	67.56	8.61	7.62	0.33	0.33	12.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	117.55	39.60	43.93	6.19	8.04	0.00	0.00	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	111.60	51.06	42.50	10.09	14.06	0.00	0.00	13.15
Adipocyte - breast, donor1	11376-118A8	86.00	26.93	24.87	7.60	6.97	0.00	0.00	3.01
Adipocyte - breast, donor2	11327-117E4	72.51	28.40	19.89	7.86	8.02	0.00	0.00	5.29
Adipocyte - omental, donor1	11473-119C6	90.97	24.55	24.30	7.38	6.49	0.00	0.00	3.94
Adipocyte - omental, donor2	11474-119C7	73.25	17.19	19.43	5.98	7.47	0.00	0.00	2.99
Adipocyte - omental, donor3	11475-119C8	94.78	26.79	16.41	4.69	5.02	0.00	0.33	5.36
Adipocyte - perirenal, donor1	11476-119C9	102.72	28.07	29.99	5.10	8.29	0.00	0.64	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	37.38	9.90	11.00	0.00	5.50	0.00	0.00	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	80.39	22.58	24.39	3.61	8.58	0.00	0.45	3.16
Adipocyte - subcutaneous, donor3	11408-118E4	71.77	16.51	18.07	6.26	7.47	0.00	0.00	7.12
Adipocyte differentiation, day04, donor1	13019-139D4	77.06	15.84	17.80	7.63	4.89	0.20	0.00	3.52
Adipocyte differentiation, day04, donor2	13022-139D7	100.12	17.24	24.71	6.18	3.35	0.26	0.26	3.35
Adipocyte differentiation, day04, donor3	13025-139E1	125.73	23.70	34.01	5.58	7.25	0.00	0.00	5.85
Adipocyte differentiation, day04, donor4	13028-139E4	127.55	32.92	30.57	6.47	5.29	0.00	0.59	5.29
Adipocyte differentiation, day08, donor1	13020-139D5	79.55	25.26	16.89	9.73	6.27	0.08	0.00	5.63
Adipocyte differentiation, day08, donor2	13023-139D8	121.03	19.69	21.30	5.81	5.81	0.00	0.32	4.20
Adipocyte differentiation, day08, donor3	13026-139E2	78.91	17.06	19.73	4.27	3.20	0.00	0.00	3.73
Adipocyte differentiation, day08, donor4	13029-139E5	132.43	38.95	25.60	2.78	5.01	0.00	0.00	5.56
Adipocyte differentiation, day12, donor1	13021-139D6	61.14	23.71	24.95	2.91	4.99	0.00	0.00	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	82.63	16.58	21.60	3.52	4.52	0.00	0.75	2.76
Adipocyte differentiation, day12, donor3	13027-139E3	84.76	19.96	19.63	4.25	3.60	0.00	0.00	3.93
Adipocyte differentiation, day12, donor4	13030-139E6	71.55	28.01	18.27	2.74	5.18	0.00	0.30	4.26
Alveolar Epithelial Cells, donor1	11510-119G7	150.94	37.57	43.32	10.61	15.03	0.00	0.22	8.18
Alveolar Epithelial Cells, donor2	11590-120G6	122.99	35.14	26.18	2.51	6.81	0.00	0.00	5.38
Alveolar Epithelial Cells, donor3	11671-122G6	86.26	8.39	13.18	2.40	2.40	0.00	0.00	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	145.72	20.87	28.96	6.30	6.84	0.00	0.00	6.66
Amniotic Epithelial Cells, donor2	11613-122A2	112.12	6.69	28.45	5.02	3.35	0.00	0.00	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	125.12	20.13	23.42	4.11	7.60	0.00	0.00	5.75
Anulus Pulposus Cell, donor1	11248-116E6	74.26	16.13	15.91	14.99	11.44	0.00	0.00	11.33
Anulus Pulposus Cell, donor2	11463-119B5	69.80	18.61	17.63	8.57	9.80	0.00	0.00	11.27
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	102.89	25.16	35.49	6.29	4.49	0.00	0.45	7.19
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	125.03	28.65	29.52	6.08	7.38	0.00	0.00	5.64
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	104.87	44.95	29.96	6.42	6.42	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	104.92	26.60	23.61	7.77	5.38	0.00	0.00	7.17
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	130.26	29.09	34.15	2.53	2.53	0.00	1.26	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	62.05	23.10	17.82	7.26	7.92	0.00	0.00	4.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	102.01	17.54	28.27	3.90	4.22	0.00	0.00	8.45
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	115.05	23.79	22.33	6.80	4.37	0.00	0.00	5.34
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	76.61	26.72	23.76	7.13	4.16	0.00	0.00	5.94
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	111.11	21.47	25.61	7.91	3.77	0.00	0.00	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	132.07	25.40	27.58	9.43	6.53	0.00	0.00	5.81
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	78.99	23.82	21.31	2.51	1.25	0.00	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	93.24	23.89	20.76	8.57	8.24	0.00	0.00	5.60
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	128.29	13.65	21.84	8.19	4.09	0.00	0.00	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	69.06	19.60	16.29	6.18	4.37	0.00	0.15	5.73
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	122.16	21.43	24.11	6.97	4.29	0.00	0.00	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	82.75	30.80	23.05	8.31	5.29	0.19	0.00	8.12
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	96.22	28.60	28.60	6.15	6.68	0.00	0.00	6.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	122.91	10.73	24.39	3.90	2.93	0.00	0.00	8.78
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	75.63	23.22	22.72	6.97	5.81	0.00	0.17	8.13
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	93.66	22.81	18.01	4.80	4.80	0.00	0.00	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	177.01	3.54	42.48	0.00	3.54	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	82.33	28.30	19.04	6.86	6.35	0.00	0.00	7.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	100.68	12.58	20.97	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	102.91	22.33	19.90	6.31	3.40	0.00	0.00	7.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	59.57	21.63	26.18	8.73	6.83	0.00	0.00	6.45
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	105.39	19.38	32.71	0.00	6.06	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	109.45	13.11	18.24	6.84	2.28	0.00	0.00	9.12
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	82.09	25.01	26.51	5.99	7.05	0.00	0.43	6.84
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	78.46	25.29	19.87	5.68	6.19	0.00	0.00	4.39
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	118.71	18.30	26.74	7.04	2.82	0.00	0.00	6.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	95.50	26.69	22.83	6.43	6.75	0.00	0.00	6.43
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	74.91	18.55	26.40	6.42	2.14	0.00	0.00	4.28
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	115.82	23.40	23.98	5.85	5.85	0.00	0.58	6.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	97.85	24.09	24.99	6.32	7.83	0.00	0.00	6.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	60.59	36.83	23.76	3.56	7.13	0.00	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	98.66	23.39	22.89	3.56	2.03	0.00	0.00	10.68
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	82.26	22.16	20.63	4.84	7.39	0.00	0.00	6.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	61.00	26.05	25.41	5.08	5.08	0.00	0.00	3.81
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	115.22	22.44	23.30	6.90	5.61	0.00	0.00	5.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	77.48	21.59	21.38	6.77	6.56	0.00	0.21	8.26
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	92.79	26.10	22.91	4.93	4.35	0.00	0.00	6.38
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	117.15	22.67	34.01	6.61	2.83	0.00	0.00	9.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	80.52	24.58	20.85	7.29	5.93	0.00	0.17	7.63
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	74.12	18.53	32.43	13.90	6.95	0.00	0.00	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	219.71	14.79	29.58	0.00	0.00	0.00	0.00	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	88.34	22.51	23.16	5.79	6.00	0.00	0.21	8.58
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	97.47	27.68	28.88	6.62	2.41	0.00	0.00	5.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	97.68	18.22	24.06	6.56	2.19	0.00	0.00	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	65.29	21.61	21.84	4.83	8.05	0.00	0.00	4.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	84.16	38.25	28.05	2.55	7.65	0.00	0.00	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	63.05	14.24	18.30	2.80	7.12	0.00	0.25	5.59
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	93.93	30.35	25.19	7.23	5.57	0.00	0.00	5.16
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	85.07	25.09	27.85	6.12	5.20	0.00	0.00	7.65
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	98.95	21.51	25.81	5.74	5.74	0.00	0.00	9.56
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	79.83	24.83	21.29	5.99	5.99	0.00	0.00	4.88
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	76.29	21.36	25.94	10.68	3.05	0.00	0.00	7.63
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	104.68	22.71	22.71	5.54	3.88	0.00	0.00	7.75
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	82.35	24.36	24.63	6.09	4.50	0.00	0.26	8.47
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	79.96	28.35	26.17	5.82	2.91	0.00	0.00	6.18
Astrocyte - cerebellum, donor1	11500-119F6	185.08	37.95	36.11	7.86	16.83	0.00	0.25	6.39
Astrocyte - cerebellum, donor2	11580-120F5	151.13	40.74	35.09	8.04	11.98	0.00	0.00	8.04
Astrocyte - cerebellum, donor3	11661-122F5	86.63	21.39	21.60	5.66	10.91	0.00	0.00	6.08
Astrocyte - cerebral cortex, donor1	11235-116D2	154.77	31.72	42.53	14.64	20.57	0.00	0.35	7.32
Astrocyte - cerebral cortex, donor2	11316-117D2	253.66	82.50	70.37	25.56	26.21	0.32	0.49	18.60
Astrocyte - cerebral cortex, donor3	11392-118C6	231.05	51.31	56.23	20.73	15.36	0.00	0.45	11.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	194.97	137.85	84.52	47.14	47.14	1.03	0.23	43.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	226.76	171.51	108.87	46.73	55.63	1.13	0.50	52.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	235.56	156.58	106.74	51.32	53.83	0.91	1.02	43.47
Basophils, donor1	12241-129G9	86.04	33.74	14.38	6.80	8.89	0.00	0.26	6.54
Basophils, donor2	12242-129H1	117.98	52.32	22.73	9.38	10.82	0.00	0.36	7.94
Basophils, donor3	12243-129H2	53.65	32.49	13.52	7.20	8.67	0.00	0.15	10.14
Bronchial Epithelial Cell, donor1	11511-119G8	62.96	24.58	20.70	8.19	6.04	0.00	0.00	6.90
Bronchial Epithelial Cell, donor2	11591-120G7	68.58	18.29	13.26	3.66	5.94	0.00	0.00	3.66
Bronchial Epithelial Cell, donor3	11672-122G7	143.47	57.39	57.39	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	56.49	33.27	33.27	6.28	14.44	0.00	0.00	7.53
Bronchial Epithelial Cell, donor5	11457-119A8	72.16	46.17	33.48	6.86	9.36	0.00	0.00	10.19
Bronchial Epithelial Cell, donor6	11461-119B3	55.04	36.85	18.42	5.30	8.98	0.00	0.23	12.21
Bronchial Epithelial Cell, donor7	11769-123I5	107.07	41.57	35.45	6.48	5.94	0.00	0.00	14.40
Burkitt's lymphoma cell line:DAUDI	10422-106C8	200.34	59.57	54.93	24.32	22.57	0.41	0.52	19.99
Burkitt's lymphoma cell line:RAJI	10476-106I8	185.86	78.49	44.72	25.15	22.82	0.93	0.93	20.96
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	149.33	62.04	53.40	29.42	26.54	0.64	0.00	24.94
CD133+ stem cells - cord blood derived, pool1	12223-129E9	206.84	62.05	41.37	20.68	20.68	0.00	0.00	41.37
CD14+ Monocytes, donor1	11224-116B9	39.45	18.03	8.45	1.69	3.38	0.00	0.00	5.64
CD14+ Monocytes, donor2	11305-117B9	73.68	25.98	16.15	6.12	7.42	0.19	0.56	9.28
CD14+ Monocytes, donor3	11381-118B4	68.50	28.98	10.76	4.61	7.68	0.00	1.10	9.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	146.33	41.04	24.62	13.30	15.28	0.00	0.00	9.91
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	158.07	39.42	30.71	8.72	10.61	0.00	0.76	5.69
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	151.88	42.41	32.55	10.85	17.75	0.00	0.00	12.16
CD14+ monocytes - mock treated, donor1	11863-125A9	96.41	75.17	43.08	12.86	16.04	0.14	1.45	18.36
CD14+ monocytes - mock treated, donor2	11873-125C1	94.45	51.60	36.51	10.56	15.09	0.30	0.91	13.58
CD14+ monocytes - mock treated, donor3	11883-125D2	100.21	64.67	39.09	9.71	14.69	0.00	0.71	13.98
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	98.60	59.09	41.35	8.70	8.70	0.33	0.50	11.89
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	131.11	70.38	59.62	5.80	11.87	0.55	1.10	8.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	131.90	49.59	52.07	9.67	11.90	0.74	1.24	14.38
CD14+ monocytes - treated with BCG, donor1	11860-125A6	114.54	96.92	71.66	9.79	14.49	0.78	0.59	9.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	137.81	113.24	69.80	10.50	18.52	0.00	1.42	16.02
CD14+ monocytes - treated with BCG, donor3	11880-125C8	118.61	78.13	53.75	9.58	17.85	0.00	0.65	12.84
CD14+ monocytes - treated with Candida, donor1	11868-125B5	76.79	28.80	25.75	4.92	6.32	0.23	1.40	8.19
CD14+ monocytes - treated with Candida, donor2	11878-125C6	127.25	41.71	44.35	5.28	9.50	0.00	1.58	6.34
CD14+ monocytes - treated with Candida, donor3	11888-125D7	118.70	32.17	46.59	6.66	7.77	0.00	0.00	6.66
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	80.47	53.85	36.74	10.11	13.98	0.30	1.34	9.52
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	93.59	49.49	36.92	7.18	12.97	0.00	1.20	10.18
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	87.86	41.22	38.52	11.24	17.28	0.00	0.62	8.95
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	68.64	47.36	37.52	8.47	12.35	0.00	0.00	9.15
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	88.90	36.42	36.19	7.01	9.73	0.00	0.00	7.69
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	67.21	27.50	23.13	8.29	8.73	0.44	0.44	10.91
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	122.39	115.67	69.94	13.45	18.83	0.27	1.08	14.26
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	122.12	124.56	67.34	14.48	20.94	0.52	2.09	19.19
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	126.25	93.42	64.39	10.94	21.88	0.84	0.84	10.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	70.73	26.27	23.15	4.23	9.74	0.37	0.73	5.33
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	143.02	42.98	44.74	4.58	11.62	0.00	0.35	7.05
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	103.98	39.49	39.49	5.70	14.04	0.00	0.00	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	137.41	97.13	78.64	10.64	9.94	1.74	3.49	11.68
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	108.90	82.88	70.25	5.95	11.15	1.12	2.60	13.01
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	126.96	78.68	70.05	10.13	18.54	0.00	0.00	12.50
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	87.63	24.57	20.06	4.09	7.37	0.00	0.00	4.50
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	102.22	21.56	28.28	6.03	9.97	0.00	0.23	7.19
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	80.27	29.00	20.42	6.73	6.73	0.23	0.23	6.26
CD14+CD16+ Monocytes, donor1	11789-124B7	106.58	45.12	31.39	13.73	16.57	0.00	0.22	13.51
CD14+CD16+ Monocytes, donor2	11801-124D1	104.41	75.54	39.96	14.32	17.56	0.46	0.00	16.86
CD14+CD16+ Monocytes, donor3	11912-125G4	107.22	46.14	30.76	13.65	22.09	0.00	0.00	13.86
CD14+CD16- Monocytes, donor1	11788-124B6	118.50	39.40	23.36	16.66	21.02	0.31	0.47	12.15
CD14+CD16- Monocytes, donor2	11799-124C8	89.59	23.23	17.29	13.97	15.54	0.00	0.70	12.75
CD14+CD16- Monocytes, donor3	11910-125G2	129.77	28.09	27.87	10.93	15.83	0.22	0.22	10.70
CD14-CD16+ Monocytes, donor1	11790-124B8	115.85	136.77	61.24	16.84	25.01	0.00	0.77	36.23
CD14-CD16+ Monocytes, donor2	11800-124C9	133.72	145.79	63.67	20.42	20.42	0.00	0.66	28.76
CD14-CD16+ Monocytes, donor3	11911-125G3	117.06	116.43	60.64	18.32	24.00	0.21	0.42	23.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	174.78	30.48	28.45	14.23	6.10	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	189.16	40.68	61.02	16.27	9.49	2.03	0.00	7.46
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	236.12	44.53	35.21	9.32	11.39	0.00	0.00	10.36
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	175.90	32.52	29.32	13.33	10.66	0.00	0.53	8.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	218.18	45.57	45.03	12.33	14.47	0.00	0.54	6.97
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	209.18	46.33	37.90	18.25	10.53	0.00	2.11	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	214.91	33.73	38.43	14.90	13.33	0.00	0.00	9.41
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	239.93	48.78	59.32	11.86	18.46	0.00	0.00	11.86
CD19+ B Cells, donor1	11544-120B5	171.78	18.90	35.34	1.64	2.47	0.00	2.47	5.75
CD19+ B Cells, donor2	11624-122B4	121.15	22.49	29.02	2.18	3.63	1.45	0.00	4.35
CD19+ B Cells, donor3	11705-123B4	119.14	28.27	29.28	3.53	4.04	1.01	0.50	7.57
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	341.83	98.99	171.72	44.45	69.90	0.00	1.21	15.35
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	234.90	73.11	133.83	31.96	56.33	0.00	1.60	17.18
CD34+ Progenitors, donor1	11545-120B6	127.51	23.09	25.10	16.06	14.06	0.00	0.00	6.02
CD34+ Progenitors, donor2	11625-122B5	147.76	42.70	23.60	5.62	9.55	0.00	0.00	6.18
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	130.39	42.84	35.70	27.43	35.32	0.00	0.00	19.92
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	153.33	55.24	43.97	38.11	31.12	0.23	0.45	25.25
CD4+ T Cells, donor1	11225-116C1	301.00	60.34	37.13	8.21	18.21	0.71	3.21	7.86
CD4+ T Cells, donor2	11306-117C1	333.13	68.58	50.83	7.96	9.80	3.67	4.29	11.02
CD4+ T Cells, donor3	11382-118B5	263.82	56.73	36.90	8.84	12.50	0.91	3.05	10.98
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	139.61	26.54	32.67	13.27	15.06	0.00	0.00	7.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	133.64	35.94	35.94	11.68	18.42	0.22	0.67	9.43
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	152.35	24.72	37.94	8.91	14.66	0.29	0.86	10.06
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	383.07	73.96	57.84	12.80	14.70	0.00	1.42	10.43
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	425.61	66.02	61.10	10.53	12.64	0.00	0.70	9.83
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	398.84	56.04	46.15	13.18	19.78	0.00	0.00	16.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	91.04	29.63	25.58	19.22	20.52	0.14	0.72	8.09
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	119.13	51.52	44.40	17.96	23.89	0.00	1.02	11.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	110.59	37.08	37.08	15.31	20.15	0.48	0.48	10.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	286.91	49.76	47.07	16.59	17.04	0.00	1.34	13.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	277.41	43.67	44.02	16.07	18.17	0.00	1.05	10.48
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	303.15	39.60	44.00	14.08	14.96	0.44	0.88	6.60
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	139.14	26.56	28.67	16.87	21.93	0.00	0.00	9.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	104.72	39.06	37.19	16.41	21.19	0.62	1.04	11.22
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	113.60	36.42	33.08	12.70	17.37	0.00	0.67	8.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	349.16	49.22	40.25	12.24	17.13	0.00	0.82	14.14
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	347.30	37.52	51.45	12.86	14.47	0.00	1.07	17.69
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	315.61	35.86	44.83	14.35	10.76	0.00	1.79	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	122.75	39.50	38.57	25.40	26.89	0.00	0.56	13.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	104.63	34.01	34.23	19.71	17.11	0.00	0.22	8.88
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	109.49	46.23	34.68	17.65	19.54	0.00	0.63	8.41
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	235.61	65.73	47.02	13.65	20.22	0.00	1.01	13.65
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	238.29	53.29	42.03	10.83	18.63	0.87	0.87	14.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	285.02	44.02	44.89	13.95	14.38	0.00	0.00	10.90
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	359.77	50.97	62.35	28.21	23.75	0.49	0.00	15.84
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	298.19	39.70	66.47	16.62	13.85	0.00	0.00	12.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	341.98	41.87	67.00	15.35	12.56	0.00	0.00	12.56
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	406.25	43.75	61.48	14.95	26.03	0.00	0.28	16.06
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	460.60	56.19	61.59	14.23	24.05	0.00	0.25	13.01
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	392.70	43.12	52.36	13.86	26.18	0.00	0.00	18.48
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	309.06	40.83	45.12	15.04	22.20	0.00	1.07	13.97
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	340.71	49.86	55.40	22.16	20.77	0.00	0.00	16.62
CD8+ T Cells, donor1	11226-116C2	176.79	55.00	31.10	5.57	11.46	0.33	1.31	8.84
CD8+ T Cells, donor2	11307-117C2	178.33	66.83	32.66	7.51	9.39	0.38	4.88	6.01
CD8+ T Cells, donor3	11383-118B6	219.92	63.63	43.18	7.07	12.12	1.01	2.78	11.11
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	160.57	36.47	59.41	11.93	7.80	0.23	0.00	13.76
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	163.44	39.54	56.32	9.83	7.19	0.24	0.24	16.77
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	180.84	48.70	58.00	7.93	11.22	0.00	0.00	11.76
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	142.60	24.32	47.13	4.80	4.50	0.00	0.00	5.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	170.15	33.60	48.96	3.60	6.96	0.00	0.24	12.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	149.85	30.47	52.07	6.82	7.28	0.00	0.00	9.78
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	166.01	43.46	53.67	11.08	16.30	0.00	0.43	16.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	189.51	53.69	64.48	12.11	13.95	0.00	0.26	19.21
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	164.63	47.84	65.20	9.38	10.32	0.00	0.23	18.76
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	151.24	44.07	51.62	12.68	14.49	0.00	0.60	17.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	166.46	53.16	58.68	15.11	13.94	0.00	0.00	18.01
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	99.91	37.30	40.76	14.12	11.46	0.27	0.00	15.72
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	84.92	24.95	32.39	6.57	9.63	0.00	0.44	15.76
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	72.41	21.86	25.96	5.01	5.47	0.46	0.91	8.20
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	129.78	26.11	57.43	8.20	6.71	0.75	0.00	14.17
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	127.49	24.85	34.21	3.60	6.84	0.00	0.72	11.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	122.86	22.73	34.53	6.91	6.04	0.00	0.29	11.22
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	136.47	32.29	35.83	6.84	5.42	0.00	0.71	11.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	90.95	35.81	40.88	9.19	8.87	0.00	0.63	12.04
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	131.33	44.29	51.36	15.07	13.23	0.00	0.92	11.99
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	105.47	38.79	40.39	13.46	10.90	0.00	0.00	13.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	107.86	37.48	34.42	9.56	9.56	0.76	0.00	14.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	117.44	39.41	50.05	10.64	9.85	0.00	0.39	11.03
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	112.71	36.31	41.60	4.54	7.56	0.00	0.00	12.86
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	116.43	34.53	36.13	4.01	7.23	1.61	0.80	10.44
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	109.81	41.97	38.47	9.09	11.19	0.00	0.70	13.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	74.13	28.05	29.05	1.00	6.01	1.00	0.00	8.01
Cardiac Myocyte, donor1	11525-119I4	191.91	34.73	43.87	27.42	16.45	0.00	0.00	10.97
Cardiac Myocyte, donor2	11605-120I3	121.05	23.22	29.15	5.93	9.39	0.00	0.00	10.38
Cardiac Myocyte, donor3	11686-122I3	95.24	36.31	31.25	14.00	11.89	0.00	0.00	9.58
Chondrocyte - de diff, donor1	11261-116G1	149.76	57.89	45.76	10.05	12.83	0.00	0.00	9.36
Chondrocyte - de diff, donor2	11338-117F6	50.46	13.50	9.24	6.75	8.53	0.00	0.00	4.98
Chondrocyte - de diff, donor3	11410-118E6	79.65	26.97	22.64	10.81	8.76	0.00	0.00	10.47
Chondrocyte - re diff, donor2	11339-117F7	92.21	23.28	29.54	11.64	6.27	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	75.62	19.41	24.26	8.49	7.28	0.00	0.40	5.66
Ciliary Epithelial Cells, donor1	11242-116D9	133.00	45.56	36.95	16.53	19.39	0.11	0.34	13.66
Ciliary Epithelial Cells, donor2	11323-117D9	104.75	39.55	31.42	13.47	10.05	0.43	0.21	8.34
Ciliary Epithelial Cells, donor3	11399-118D4	108.32	37.26	34.07	16.02	10.97	0.18	0.44	13.01
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	143.51	35.95	30.63	16.41	12.29	0.64	0.73	10.91
Corneal Epithelial Cells, donor1	11526-119I5	67.63	23.06	21.08	5.05	7.69	0.00	0.00	6.81
Corneal Epithelial Cells, donor2	11606-120I4	91.01	29.58	39.82	4.55	4.55	0.00	0.00	7.96
Corneal Epithelial Cells, donor3	11687-122I4	88.70	60.84	43.71	9.46	8.69	0.00	0.26	8.95
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	122.34	20.80	20.47	1.65	1.98	0.00	0.00	2.48
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	110.71	21.13	21.76	2.21	1.58	0.00	0.63	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	124.23	10.35	24.15	6.90	0.00	0.00	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	81.21	21.27	15.77	4.10	3.02	0.00	0.11	3.89
Dendritic Cells - plasmacytoid, donor1	11228-116C4	66.96	27.67	21.87	12.64	17.42	0.00	0.68	7.17
Dendritic Cells - plasmacytoid, donor2	11309-117C4	75.73	41.13	18.28	11.75	20.24	0.00	0.00	9.79
Dendritic Cells - plasmacytoid, donor3	11385-118B8	90.01	52.27	21.78	13.07	25.65	0.00	0.00	10.16
Endothelial Cells - Aortic, donor0	11207-116A1	100.56	45.86	32.02	19.51	20.35	0.00	0.00	12.67
Endothelial Cells - Aortic, donor1	11263-116G3	102.69	36.97	26.40	14.67	5.28	0.00	0.00	11.15
Endothelial Cells - Aortic, donor2	11340-117F8	218.89	48.64	41.29	13.29	12.16	0.00	0.00	8.48
Endothelial Cells - Aortic, donor3	11412-118E8	113.24	43.25	28.70	12.19	14.15	0.00	0.39	11.80
Endothelial Cells - Artery, donor1	11264-116G4	84.94	29.38	25.89	7.56	7.56	0.00	0.29	5.24
Endothelial Cells - Artery, donor2	11341-117F9	127.52	44.94	35.76	16.23	17.88	0.00	0.24	14.59
Endothelial Cells - Artery, donor3	11413-118E9	116.23	39.44	32.26	17.36	16.13	0.18	0.00	12.45
Endothelial Cells - Lymphatic, donor1	11236-116D3	127.45	18.62	25.05	9.75	6.21	0.00	0.44	4.43
Endothelial Cells - Lymphatic, donor2	11317-117D3	129.92	15.52	27.99	6.09	4.26	0.00	0.00	3.65
Endothelial Cells - Lymphatic, donor3	11393-118C7	180.42	15.22	21.71	4.23	4.51	0.28	0.28	4.79
Endothelial Cells - Microvascular, donor1	11265-116G5	70.42	19.61	13.97	4.75	4.16	0.00	0.30	5.65
Endothelial Cells - Microvascular, donor2	11342-117G1	69.77	14.06	17.18	4.69	4.69	0.00	0.00	7.29
Endothelial Cells - Microvascular, donor3	11414-118F1	65.08	8.37	8.93	4.11	3.83	0.00	0.14	4.68
Endothelial Cells - Thoracic, donor1	11266-116G6	214.06	72.02	50.42	14.40	14.40	0.40	0.00	13.60
Endothelial Cells - Thoracic, donor2	11343-117G2	93.29	23.06	18.87	9.43	6.29	0.00	0.00	8.39
Endothelial Cells - Umbilical vein, donor1	11243-116E1	204.63	63.12	57.28	30.56	22.49	0.00	0.12	15.16
Endothelial Cells - Umbilical vein, donor2	11324-117E1	148.61	49.54	44.32	22.38	18.90	0.00	0.22	16.08
Endothelial Cells - Umbilical vein, donor3	11400-118D5	236.19	93.43	71.32	24.79	19.66	0.00	0.00	26.50
Endothelial Cells - Vein, donor1	11267-116G7	101.24	28.44	26.16	12.51	15.93	0.00	0.00	7.96
Endothelial Cells - Vein, donor2	11344-117G3	65.66	20.96	24.45	8.38	10.48	0.00	0.00	11.18
Endothelial Cells - Vein, donor3	11416-118F3	115.87	42.39	34.54	17.27	11.62	0.00	0.00	15.70
Eosinophils, donor1	12244-129H3	213.46	106.73	0.00	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	70.96	21.45	6.60	0.00	3.30	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	53.50	14.27	14.27	3.57	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	73.30	18.57	22.48	4.89	8.55	0.00	0.00	10.99
Esophageal Epithelial Cells, donor2	11587-120G3	95.69	31.20	14.56	0.00	2.08	0.00	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	32.54	32.54	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	75.53	37.36	37.77	6.98	8.62	0.00	0.00	4.93
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	56.71	38.65	27.37	5.91	3.28	0.00	0.00	8.65
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	162.07	73.89	75.84	13.76	9.75	0.00	0.00	15.17
Fibroblast - Aortic Adventitial, donor1	11245-116E3	99.09	53.12	29.83	16.49	12.98	0.00	0.00	8.13
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	63.32	34.25	20.74	7.78	7.10	0.27	0.68	5.87
Fibroblast - Aortic Adventitial, donor2	11326-117E3	77.94	37.44	29.11	9.18	7.91	0.00	0.11	7.91
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	133.06	40.58	36.89	7.38	6.59	0.00	0.26	5.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	133.54	52.82	51.82	18.94	18.94	0.00	0.33	17.61
Fibroblast - Cardiac, donor1	11268-116G8	71.67	33.57	30.85	8.17	11.79	0.00	0.00	12.25
Fibroblast - Cardiac, donor2	11345-117G4	78.07	18.19	20.46	7.58	6.06	0.00	0.00	8.34
Fibroblast - Cardiac, donor3	11417-118F4	61.82	25.23	18.30	7.10	3.63	0.00	0.00	5.05
Fibroblast - Cardiac, donor4	11452-119A3	100.63	26.07	23.95	11.52	6.06	0.00	0.00	9.40
Fibroblast - Cardiac, donor5	11456-119A7	116.12	40.61	33.76	12.18	12.94	0.00	0.13	12.31
Fibroblast - Cardiac, donor6	11460-119B2	162.66	61.85	44.57	10.61	12.89	0.00	0.15	11.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	120.06	22.64	18.76	4.82	7.24	0.00	0.00	4.42
Fibroblast - Choroid Plexus, donor2	11572-120E6	76.36	22.87	24.59	8.20	8.20	0.00	0.00	7.33
Fibroblast - Choroid Plexus, donor3	11653-122E6	169.92	46.87	45.41	26.37	7.32	0.00	0.00	11.72
Fibroblast - Conjunctival, donor1	11531-120A1	143.92	36.90	48.20	13.61	21.22	0.00	0.00	10.15
Fibroblast - Conjunctival, donor3	11692-122I9	109.39	16.28	17.30	7.97	11.02	0.00	0.17	13.40
Fibroblast - Dermal, donor1	11269-116G9	79.59	40.38	24.18	14.32	12.68	0.00	0.00	15.26
Fibroblast - Dermal, donor2	11346-117G5	103.77	33.49	37.73	10.85	12.74	0.00	0.00	9.43
Fibroblast - Dermal, donor3	11418-118F5	82.44	36.27	25.27	16.56	15.59	0.00	0.00	15.47
Fibroblast - Dermal, donor4	11450-119A1	206.53	101.74	73.03	21.37	31.77	0.11	0.23	24.30
Fibroblast - Dermal, donor5	11454-119A5	254.70	115.31	89.15	18.67	36.29	0.00	0.17	21.63
Fibroblast - Dermal, donor6	11458-119A9	282.45	134.65	100.86	24.85	34.11	0.65	0.16	21.93
Fibroblast - Gingival, donor1	11237-116D4	89.12	29.57	22.91	9.37	13.33	0.00	0.00	12.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	138.34	61.05	44.80	12.05	11.53	0.00	0.00	13.10
Fibroblast - Gingival, donor2	11318-117D4	215.73	67.08	56.14	23.59	21.74	0.40	0.92	14.89
Fibroblast - Gingival, donor3	11394-118C8	109.93	25.43	27.85	13.25	10.93	0.00	0.00	16.53
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	96.62	28.05	19.74	13.51	3.12	1.04	0.00	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	107.84	30.48	29.43	9.87	8.46	0.00	0.00	4.58
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	157.77	89.02	57.53	21.67	22.76	0.16	0.16	16.68
Fibroblast - Gingival, donor6 (control)	11922-125H5	187.56	70.86	51.39	14.47	15.15	0.00	0.00	12.04
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	410.05	172.56	129.86	12.70	13.06	0.00	0.00	21.88
Fibroblast - Gingival, donor7 (control)	11924-125H7	206.50	82.63	64.79	15.65	15.36	0.00	0.00	12.28
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	186.26	76.90	64.22	16.64	17.59	0.00	0.14	14.04
Fibroblast - Gingival, donor8 (control)	11926-125H9	244.18	129.66	111.34	18.87	22.49	0.00	0.11	18.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	182.69	48.42	46.66	10.42	8.66	0.00	0.15	8.36
Fibroblast - Lung, donor1	11270-116H1	72.05	12.23	17.67	5.44	6.80	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	143.25	34.32	17.91	17.91	8.95	0.00	0.00	13.43
Fibroblast - Lung, donor3	11419-118F6	117.34	33.55	32.50	24.48	18.99	0.00	0.00	12.87
Fibroblast - Lymphatic, donor1	11506-119G3	195.76	27.49	33.32	3.33	19.16	0.00	0.00	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	111.89	27.97	29.37	8.39	6.99	0.00	0.00	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	45.06	10.08	11.20	4.48	7.84	0.00	0.00	3.64
Fibroblast - Mammary, donor1	11540-120B1	211.10	52.37	47.90	17.46	15.43	0.00	0.00	11.77
Fibroblast - Mammary, donor2	11620-122A9	75.89	31.95	23.97	7.99	19.97	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	154.86	23.83	29.78	5.96	23.83	0.00	0.00	35.74
Fibroblast - Periodontal Ligament, donor1	11238-116D5	188.74	61.30	51.21	25.99	24.05	0.00	0.39	14.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	304.12	100.87	93.89	27.00	34.58	0.15	0.46	21.39
Fibroblast - Periodontal Ligament, donor3	11395-118C9	154.83	52.63	33.66	13.46	13.77	0.31	0.00	9.49
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	129.37	45.03	48.08	12.21	11.07	0.38	0.00	11.07
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	75.60	29.97	27.00	15.39	13.77	0.00	0.00	7.56
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	110.41	35.95	30.97	13.92	10.55	0.00	0.00	9.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	128.00	64.66	43.99	20.78	16.03	0.00	0.00	14.04
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	165.80	43.08	33.32	11.18	22.15	0.20	0.20	8.94
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	138.99	38.09	40.76	12.70	14.70	0.00	0.00	7.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	93.31	32.81	28.86	12.26	9.49	0.00	0.00	11.86
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	184.95	64.69	40.28	10.72	14.88	0.40	1.19	12.90
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	69.80	13.14	16.87	9.59	7.82	0.18	0.36	7.82
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	94.21	24.83	25.23	9.46	10.45	0.00	0.00	7.49
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	123.95	34.90	33.09	9.03	9.93	0.00	0.00	9.03
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	120.15	40.27	30.77	11.33	14.68	0.00	0.00	7.88
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	122.74	33.41	22.78	9.62	7.34	0.00	0.76	6.58
Fibroblast - skin normal, donor1	11553-120C5	69.41	22.31	17.56	9.35	10.99	0.00	0.16	7.22
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	94.04	43.11	34.29	10.03	12.43	0.40	0.00	5.41
Fibroblast - skin normal, donor2	11561-120D4	132.11	51.34	39.18	12.36	12.46	0.00	0.10	7.23
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	175.90	53.80	39.29	14.51	18.44	0.00	0.00	10.88
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	97.26	24.44	23.45	9.44	10.27	0.00	0.08	7.46
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	154.54	25.47	24.10	7.86	10.94	0.00	0.17	8.38
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	127.10	25.95	28.57	2.96	7.23	0.00	0.33	8.54
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	122.61	56.35	35.58	11.40	15.34	0.00	0.11	8.42
Fibroblast - skin walker warburg, donor1	11554-120C6	105.59	36.44	31.54	17.88	17.88	0.00	0.00	11.81
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	72.45	28.85	21.33	8.00	7.53	0.00	0.00	8.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	553.99	332.40	132.96	44.32	44.32	0.00	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	135.09	50.55	35.73	9.59	4.36	0.00	0.87	14.82
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	95.00	42.65	32.07	7.80	8.32	0.00	0.17	7.28
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	81.72	48.67	34.87	7.81	11.71	0.00	0.00	7.29
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	90.20	63.62	43.69	9.96	9.20	0.26	0.00	7.67
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	557.32	135.50	163.06	19.14	22.97	0.77	0.00	21.44
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	585.11	150.58	165.26	17.87	33.82	0.00	0.00	26.80
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	775.92	202.82	201.97	31.38	20.25	0.29	0.29	29.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	547.65	76.38	62.60	36.68	19.58	0.55	0.83	34.19
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	348.20	60.28	67.58	15.75	11.64	0.23	0.46	16.90
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	657.99	157.12	159.10	29.72	19.61	0.00	0.40	30.12
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	508.32	75.34	62.12	34.63	14.01	0.79	1.32	24.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	342.78	46.97	46.64	15.98	12.07	0.00	0.33	15.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	864.99	200.77	204.75	36.70	21.67	0.00	0.88	38.03
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	532.93	88.89	106.13	42.82	32.93	0.28	0.85	37.87
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	407.85	71.55	85.71	23.64	20.81	0.00	0.00	27.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	430.34	113.63	104.50	24.18	23.37	0.00	0.54	26.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	380.23	39.65	61.45	18.34	15.86	0.12	0.00	10.78
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	467.60	44.16	79.32	19.66	20.21	0.28	0.00	16.89
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	428.97	68.72	83.35	20.94	17.28	0.20	0.61	18.70
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	319.22	35.82	48.15	8.67	11.64	0.00	0.23	11.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	375.57	37.12	61.78	12.08	12.71	0.37	0.25	14.57
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	447.21	59.67	67.54	12.02	10.93	0.44	0.44	19.67
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	294.30	33.98	54.66	10.93	15.07	0.00	0.59	7.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	373.87	33.54	65.49	17.01	13.67	0.00	0.32	11.29
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	376.91	52.06	64.79	12.96	14.08	0.00	0.22	12.29
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	301.44	34.88	51.01	12.30	18.55	0.00	0.20	9.48
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	317.91	43.77	64.80	15.61	21.71	0.17	0.17	11.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	389.89	41.32	51.61	13.48	15.34	0.00	0.00	9.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	336.52	26.01	33.71	9.26	8.74	0.10	0.10	7.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	330.96	17.42	32.96	6.15	9.22	0.00	0.00	6.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	291.79	33.09	53.56	13.50	18.37	0.00	0.22	13.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	306.49	37.27	44.68	12.65	15.56	0.00	0.17	9.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	297.90	26.95	37.16	8.78	8.78	0.00	0.00	11.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	257.88	29.71	47.86	10.32	12.79	0.00	0.00	11.97
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	315.79	31.01	51.54	15.91	14.64	0.00	0.23	13.49
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	255.32	42.36	50.53	13.34	14.34	0.33	0.00	10.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	270.91	31.74	43.20	7.27	9.26	0.22	0.22	9.92
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	314.86	30.50	50.43	12.18	13.78	0.00	0.00	11.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	236.66	42.95	58.19	12.16	16.05	0.00	0.97	15.40
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	335.47	21.49	49.71	8.34	9.30	0.00	0.32	10.26
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	242.00	30.13	49.56	14.78	13.55	0.00	0.19	15.44
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	219.71	41.28	43.81	12.50	12.97	0.00	0.00	14.55
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	197.35	38.32	37.40	13.08	9.12	0.00	0.30	10.03
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	227.48	32.41	49.13	13.28	15.68	0.00	0.10	10.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	204.19	32.27	38.64	9.00	10.54	0.22	0.00	13.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	235.66	31.70	42.64	12.06	11.78	0.00	0.00	10.38
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	185.27	30.65	41.11	12.13	10.65	0.09	0.09	10.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	192.26	37.44	51.34	11.50	13.64	0.00	0.00	10.16
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	200.59	51.10	43.15	11.78	8.72	0.15	0.00	9.49
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	187.96	36.27	44.17	15.16	12.69	0.00	0.00	10.62
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	202.76	34.70	45.27	9.49	10.30	0.27	0.00	7.59
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	187.49	30.79	31.52	9.40	10.32	0.00	0.00	6.82
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	170.19	29.61	41.45	6.58	9.87	0.00	0.22	7.68
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	355.05	58.51	62.48	9.92	11.90	0.00	0.00	16.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	167.79	34.82	37.46	11.74	10.03	0.00	0.13	8.84
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	167.66	33.90	31.88	8.47	8.68	0.00	0.00	9.48
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	216.29	13.98	33.55	4.07	3.81	0.00	0.00	6.10
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	720.80	137.35	114.06	22.10	34.64	0.00	0.20	22.89
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	481.49	98.30	115.25	37.13	31.43	0.00	0.00	38.52
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	629.09	86.33	136.05	44.60	33.96	0.00	0.61	36.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	325.45	70.10	84.80	24.41	19.71	0.00	0.31	10.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	337.65	73.18	78.55	22.60	17.24	0.00	0.00	15.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	332.07	58.11	62.26	24.91	17.99	0.46	0.00	13.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	324.20	66.82	59.40	12.37	22.27	0.00	0.00	29.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	324.15	70.79	75.04	18.18	20.11	0.00	1.16	18.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	438.02	81.83	81.83	14.44	9.63	0.00	0.00	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	359.94	64.34	88.68	20.87	15.65	0.00	1.74	12.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	319.30	61.52	63.47	15.30	11.07	0.00	0.00	16.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	340.15	46.53	74.12	15.65	15.65	0.41	0.00	16.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	406.54	56.65	103.30	16.66	16.66	3.33	0.00	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	316.28	46.42	61.52	10.35	13.14	0.00	0.28	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	348.09	47.07	70.27	15.69	12.75	0.65	0.65	16.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	306.18	51.17	67.11	20.13	14.26	0.00	0.84	15.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	391.55	44.21	69.34	16.86	13.68	0.32	0.64	19.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	364.80	44.16	66.57	13.59	10.19	0.00	0.34	11.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	283.99	31.32	52.20	12.53	16.71	0.00	0.00	14.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	463.89	48.68	84.76	21.19	20.62	0.00	0.57	17.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	309.89	27.53	52.68	10.95	9.47	0.00	0.00	7.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	257.51	40.66	57.60	1.69	13.55	0.00	0.00	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	301.13	47.63	56.75	19.88	14.50	0.00	0.00	14.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	317.35	52.24	66.97	19.79	11.74	0.00	0.46	10.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	326.65	31.61	63.22	10.54	15.81	0.00	0.00	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	248.71	27.68	39.98	14.99	7.30	0.77	0.38	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	275.44	34.55	49.22	11.41	11.08	0.65	0.65	9.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	352.48	37.46	46.82	10.70	12.04	0.00	0.00	14.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	334.41	25.43	53.94	11.94	11.94	0.00	0.00	15.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	346.45	45.19	52.38	15.75	15.06	0.34	0.34	13.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	370.23	9.94	34.79	14.91	7.45	0.00	0.00	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	391.64	30.67	61.81	12.27	15.57	0.00	0.94	15.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	357.27	28.36	45.26	15.69	13.28	0.00	0.00	15.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	360.65	34.59	58.50	14.75	14.24	0.00	0.51	19.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	308.70	34.30	59.83	11.97	9.17	0.80	1.20	11.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	319.20	17.76	39.96	9.37	6.91	0.00	0.99	9.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	325.80	20.07	42.50	9.44	9.44	0.00	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	300.47	19.25	38.51	12.84	8.17	0.00	0.00	8.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	411.67	16.24	43.01	7.46	10.53	0.00	0.00	8.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	233.96	22.04	34.76	4.24	7.63	0.85	0.00	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	156.99	23.88	26.86	7.76	8.36	0.00	0.60	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	181.00	23.29	35.42	10.68	10.19	0.00	0.00	6.79
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	6.85	17.12	1.14	5.71	0.00	0.00	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	35.34	13.72	10.81	8.73	8.73	0.00	0.00	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	114.69	33.73	25.86	15.74	13.49	0.00	0.00	9.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	66.29	17.44	13.64	4.44	5.39	0.00	0.00	9.20
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	31.33	9.61	14.20	5.01	5.85	0.00	0.00	10.86
Hep-2 cells mock treated, biol_rep1	11898-125E8	193.91	146.79	97.82	25.30	25.18	0.12	0.23	27.50
Hep-2 cells mock treated, biol_rep2	11899-125E9	177.41	125.76	95.88	22.11	20.76	0.00	0.51	27.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	166.53	110.79	104.88	23.89	18.43	0.46	0.46	27.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	194.90	150.41	105.37	24.70	21.42	0.22	0.44	25.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	197.93	127.23	93.49	21.49	21.71	0.00	0.00	24.71
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	174.81	115.61	101.40	20.45	22.39	0.22	0.00	25.40
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	197.39	132.88	100.38	23.16	24.28	0.00	0.00	22.91
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	179.61	111.34	101.21	20.24	19.73	0.00	0.34	24.70
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	157.30	99.32	78.81	17.94	20.50	0.32	0.00	24.03
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	231.12	29.10	42.53	4.48	7.28	0.00	0.00	10.07
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	138.06	37.65	35.49	7.36	15.58	0.00	0.00	8.22
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	116.33	60.81	52.88	5.29	2.64	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	90.30	17.64	14.46	9.52	11.29	0.00	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	85.73	20.34	17.44	5.81	6.54	0.00	0.00	5.09
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	135.85	61.54	48.26	21.16	13.81	0.17	0.00	14.34
Hepatocyte, donor1	11523-119I2	105.32	65.37	39.95	12.11	7.26	0.00	2.42	7.26
Hepatocyte, donor2	11603-120I1	173.45	29.09	40.94	9.70	11.85	0.00	1.08	8.62
Hepatocyte, donor3	11684-122I1	179.77	58.90	55.22	6.14	12.27	0.00	2.45	10.43
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	200.37	89.42	55.48	26.76	36.55	0.00	0.65	20.89
Intestinal epithelial cells (polarized), donor1	11246-116E4	165.17	51.39	33.91	9.79	13.11	0.35	0.00	9.61
Iris Pigment Epithelial Cells, donor1	11530-119I9	112.51	41.30	39.24	14.27	10.29	0.14	0.14	10.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	114.62	38.21	38.21	3.18	15.92	0.00	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	20.03	20.03	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	27.08	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	88.60	48.45	30.46	4.15	8.31	0.00	0.00	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	57.56	25.03	22.52	2.50	2.50	0.00	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	178.02	83.08	71.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	112.77	53.82	30.75	10.25	10.25	0.00	0.00	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	82.27	13.71	36.57	0.00	0.00	0.00	0.00	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	142.94	51.98	48.73	16.24	3.25	0.00	0.00	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	133.38	61.69	48.35	20.01	13.34	0.00	0.00	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	105.29	21.78	29.04	14.52	14.52	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	125.73	38.38	46.32	11.91	9.26	0.00	0.00	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	106.43	44.35	41.02	13.30	9.98	0.00	0.00	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	41.91	52.38	5.24	10.48	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	134.79	49.13	69.91	12.60	13.86	0.00	0.00	12.60
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	83.52	61.86	38.67	13.92	13.92	0.00	0.00	12.37
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	29.27	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	124.69	59.44	47.81	12.27	9.69	0.00	0.00	10.98
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	104.65	56.35	37.03	16.10	16.10	0.00	0.00	19.32
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	167.27	47.79	35.84	35.84	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	146.68	49.71	49.71	14.67	16.30	0.00	0.00	14.67
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	83.12	28.97	28.13	7.98	7.98	0.00	0.00	3.36
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	129.35	14.37	14.37	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	126.98	47.42	47.42	15.27	16.07	0.00	0.00	13.66
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	108.02	42.47	41.55	6.46	11.08	0.00	0.00	12.93
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	60.32	30.16	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	131.23	63.25	72.69	16.52	19.83	0.47	0.00	14.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	78.91	47.16	39.00	13.60	14.51	0.00	0.00	8.16
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	162.17	29.48	14.74	14.74	29.48	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	136.67	45.20	47.35	15.07	17.22	0.00	0.00	11.84
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	87.66	55.90	36.84	7.62	8.89	0.00	0.00	10.16
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	16.43	49.29	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	125.62	40.17	49.74	15.94	15.30	0.00	0.00	10.20
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	100.25	45.57	45.57	7.29	5.47	0.00	0.00	10.94
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	31.61	63.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	122.11	45.70	43.56	15.00	15.00	0.00	0.00	16.42
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	63.05	53.09	6.64	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	114.51	52.78	49.39	22.84	19.14	0.00	0.00	15.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	91.31	45.66	38.63	15.80	7.02	0.00	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	94.29	37.72	50.29	12.57	6.29	0.00	0.00	12.57
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	132.82	63.98	59.80	9.04	13.21	0.00	0.00	9.74
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	81.88	42.05	35.41	15.49	19.92	0.00	0.00	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	106.99	25.94	38.90	16.21	6.48	0.00	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	97.66	30.52	37.49	15.69	15.69	0.00	0.87	12.21
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	89.99	53.99	31.50	22.50	18.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	94.08	10.45	24.39	6.97	10.45	0.00	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	86.41	29.87	30.94	7.47	11.73	0.00	0.00	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	87.28	44.33	36.02	8.31	19.40	0.00	0.00	6.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	94.04	34.20	48.44	5.70	11.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	111.37	38.66	46.02	11.97	12.89	0.00	0.00	11.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	93.78	9.08	12.10	12.10	24.20	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	6.21	31.04	18.63	6.21	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	76.13	20.09	24.32	2.11	9.52	0.00	0.00	7.40
Keratinocyte - epidermal, donor1	11272-116H3	77.44	37.05	27.09	5.96	6.45	0.08	0.00	6.28
Keratinocyte - epidermal, donor2	11349-117G8	38.65	19.33	11.71	2.93	7.03	0.00	0.00	7.03
Keratinocyte - epidermal, donor3	11421-118F8	107.34	72.98	53.01	18.65	17.32	0.00	0.09	19.69
Keratinocyte - oral, donor1	11251-116E9	124.98	51.76	39.96	23.73	19.30	0.00	0.34	25.09
Keratocytes, donor1	11527-119I6	125.84	31.29	23.04	18.91	26.48	0.00	0.00	7.56
Keratocytes, donor2	11607-120I5	116.01	28.12	44.53	11.72	12.89	0.00	0.00	5.86
Keratocytes, donor3	11688-122I5	157.68	48.41	43.67	10.28	14.42	0.00	0.00	12.65
Krukenberg tumor cell line:HSKTC	10687-109F3	134.07	68.14	39.56	15.39	17.58	0.00	0.00	13.19
Lens Epithelial Cells, donor1	11529-119I8	118.66	49.62	35.60	5.39	16.18	0.00	0.00	17.26
Lens Epithelial Cells, donor2	11609-120I7	129.40	21.34	22.49	13.61	16.15	0.00	0.46	9.57
Lens Epithelial Cells, donor3	11690-122I7	108.88	27.85	24.92	11.40	9.38	0.00	0.00	6.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	90.95	22.77	20.28	14.70	11.86	0.00	0.12	7.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	98.51	25.95	19.26	10.33	7.26	0.28	0.28	6.98
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	137.26	37.31	34.95	11.02	12.91	0.00	0.31	11.33
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	80.66	17.74	23.66	8.07	5.38	0.54	0.00	7.53
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	94.86	19.86	25.21	7.88	7.56	0.00	0.00	6.62
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	94.66	21.89	18.98	7.12	6.47	0.00	0.00	6.68
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	78.80	13.95	17.24	5.75	12.31	0.00	0.41	6.57
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	65.99	12.89	12.14	5.06	4.55	0.00	0.25	5.56
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	89.94	21.39	18.86	7.88	6.47	0.00	0.00	6.05
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	77.52	18.59	17.80	8.31	7.12	0.40	0.00	7.12
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	108.57	23.65	21.91	10.47	10.86	0.00	0.39	7.95
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	62.21	14.07	12.03	4.26	5.00	0.00	0.00	3.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	80.49	21.95	25.09	10.80	6.97	0.00	0.00	8.71
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	107.34	20.75	23.38	10.26	8.35	0.00	0.00	8.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	87.49	20.46	17.99	7.69	7.55	0.00	0.00	5.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	78.53	18.48	20.94	11.39	6.78	0.00	0.31	7.70
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	61.73	14.34	18.39	6.55	3.74	0.00	0.00	4.68
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	97.53	19.76	19.76	8.23	8.23	0.00	0.00	7.69
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	74.38	15.47	23.04	11.52	9.22	0.00	0.00	6.25
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	82.30	15.52	14.35	3.22	8.20	0.00	0.00	3.22
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	81.90	16.18	13.69	5.23	4.48	0.00	0.00	3.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	92.63	16.49	21.82	9.21	9.70	0.00	0.97	6.79
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	101.26	21.27	22.89	9.43	9.69	0.27	0.27	7.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	113.38	25.58	23.01	8.02	9.84	0.00	0.00	6.81
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	87.61	12.44	17.11	9.33	6.22	0.00	0.52	6.74
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	109.51	26.59	21.15	8.59	8.17	0.21	0.00	8.79
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	103.46	24.51	21.35	5.71	6.92	0.00	0.15	7.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	95.61	19.95	25.45	6.88	3.44	0.00	0.00	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	102.35	21.26	20.13	9.60	6.40	0.00	0.00	7.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	65.84	18.56	14.95	5.41	6.04	0.00	0.21	5.09
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	87.71	20.84	17.44	6.78	6.30	0.00	0.00	7.75
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	103.54	19.85	24.15	6.95	8.93	0.33	0.00	5.62
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	73.84	16.73	14.25	7.81	5.58	0.00	0.00	4.83
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	97.37	24.06	25.91	11.11	9.63	0.00	0.00	4.07
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	99.57	21.00	18.78	9.39	7.66	0.00	0.25	5.68
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	86.76	18.42	16.77	7.42	6.87	0.00	0.00	4.81
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	87.49	19.62	20.91	10.61	9.33	0.00	0.00	10.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	125.38	27.39	24.35	10.04	11.87	0.00	0.00	7.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	106.65	24.77	21.97	13.44	7.42	0.14	0.00	6.44
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	95.65	19.91	18.13	8.89	6.04	0.00	0.36	7.47
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	92.59	16.97	17.45	7.27	4.36	0.00	0.00	2.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	52.75	12.60	13.23	4.98	3.58	0.00	0.00	3.42
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	79.50	22.56	20.77	7.16	5.37	0.00	0.00	10.03
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	113.68	23.85	28.42	9.15	5.55	0.33	0.00	7.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	60.50	10.83	13.65	3.06	3.06	0.00	0.24	4.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	93.80	22.65	21.78	11.76	8.54	0.12	0.00	7.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	60.70	12.29	10.50	5.38	3.33	0.00	0.00	4.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	71.90	14.02	19.69	7.76	7.16	0.00	0.00	7.76
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	140.49	122.36	45.32	9.06	6.80	0.00	0.00	36.26
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	130.41	76.71	61.37	8.44	11.51	0.00	0.00	35.29
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	113.56	59.38	42.31	5.94	8.91	0.00	0.00	27.46
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	158.67	95.63	67.70	8.89	12.27	0.00	0.85	24.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	135.04	86.51	48.53	7.74	14.07	0.00	0.00	27.43
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	126.09	70.05	57.91	4.67	7.47	0.00	0.00	22.42
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	124.70	65.95	43.28	6.70	5.15	0.00	0.00	21.13
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	111.81	77.31	51.15	10.71	14.27	0.00	0.00	24.98
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	105.41	81.88	41.17	12.89	13.80	0.23	0.23	19.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	145.70	83.47	59.62	10.47	13.38	0.29	0.29	23.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	126.95	85.53	55.82	11.25	9.45	0.00	0.45	31.06
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	133.86	95.52	47.96	10.57	12.60	0.00	0.27	20.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	162.27	92.95	62.14	13.87	10.27	0.00	0.51	26.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	133.03	93.86	56.10	12.70	12.35	0.00	0.35	37.40
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	135.26	64.63	54.64	13.99	8.00	0.00	0.67	26.65
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	167.59	101.37	68.77	13.24	9.68	0.00	0.00	24.96
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	129.93	103.52	57.10	13.87	11.21	0.53	0.27	33.35
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	140.76	97.87	54.61	11.53	13.60	0.19	0.38	30.04
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	177.32	110.44	69.33	12.88	11.04	0.61	0.00	26.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	145.15	97.85	69.31	13.05	12.23	0.00	0.00	40.77
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	134.11	108.49	57.48	14.16	12.49	0.00	0.21	35.82
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	166.47	106.78	59.98	11.77	8.41	0.00	0.56	29.99
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	161.76	84.49	61.82	15.46	13.39	1.03	0.00	26.79
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	135.57	100.15	64.74	13.06	11.03	0.00	0.87	32.51
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	169.49	104.63	55.30	11.96	9.86	0.90	0.60	25.71
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	133.89	92.39	53.67	14.38	11.07	0.00	0.00	28.22
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	158.72	99.33	57.62	11.67	16.61	0.00	0.00	33.93
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	186.97	95.51	66.75	14.01	16.96	0.37	1.48	25.81
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	135.85	81.74	56.41	8.06	12.66	0.00	0.00	28.78
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	148.51	96.32	52.57	11.13	12.28	0.38	0.00	26.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	163.05	91.15	56.05	9.06	15.85	0.00	0.57	18.12
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	154.25	89.43	64.00	8.20	7.38	0.00	1.64	37.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	150.03	84.50	59.65	9.49	14.91	0.00	0.45	25.76
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	152.96	94.08	53.14	10.05	12.21	0.00	2.15	26.57
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	147.14	98.59	65.73	14.19	10.46	0.00	0.00	34.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	147.15	102.56	57.23	17.46	11.52	0.37	0.00	20.81
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	157.22	111.13	62.03	11.20	9.05	0.00	0.43	19.38
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	131.87	98.47	65.08	9.42	14.56	0.00	0.00	29.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	146.26	87.96	62.64	10.66	9.66	0.33	0.00	27.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	166.51	89.29	52.49	7.84	12.07	0.00	0.00	16.89
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	130.11	61.86	46.93	12.09	8.53	0.00	0.00	20.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	116.18	78.37	49.50	7.56	8.59	0.00	0.00	24.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	167.47	71.39	51.53	10.20	11.27	0.00	1.07	15.57
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	127.27	80.80	41.75	6.73	10.77	0.00	0.00	28.95
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	146.68	90.38	56.67	10.74	12.22	0.74	0.74	22.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	176.77	106.99	50.01	9.30	8.14	0.00	1.16	23.26
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	114.24	58.18	48.66	6.35	11.64	0.00	0.00	22.21
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	150.86	83.23	58.82	9.20	8.80	0.00	0.00	24.41
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	185.35	103.22	63.24	15.99	7.27	0.00	0.00	27.62
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	143.34	100.41	42.92	13.03	9.20	0.00	0.00	31.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	160.32	94.71	56.23	12.33	7.89	0.00	0.00	26.14
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	173.13	96.92	63.98	7.53	12.23	0.00	0.00	21.64
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	155.87	95.03	56.82	12.57	11.06	0.00	0.50	28.66
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	139.24	86.52	58.13	9.46	10.81	0.00	0.90	27.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	201.37	74.01	51.63	5.16	3.44	0.00	0.00	15.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	140.28	99.76	53.44	9.80	11.58	0.00	0.00	32.06
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	161.10	91.11	55.53	10.17	9.78	0.39	0.39	24.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	165.59	91.70	50.14	11.88	11.22	0.00	0.00	18.47
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	159.83	91.33	50.85	8.30	9.34	0.00	0.52	29.58
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	161.90	116.83	68.70	9.63	12.69	0.00	0.88	31.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	181.71	110.70	69.89	11.18	14.54	0.00	0.56	26.84
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	140.88	104.23	51.67	11.04	7.95	0.00	0.88	24.73
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	172.41	99.90	56.70	9.26	10.41	0.00	0.39	31.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	179.25	83.04	58.23	9.62	8.61	0.51	0.00	27.34
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	141.30	92.28	53.83	8.17	12.98	0.00	0.96	26.91
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	137.95	76.33	63.61	9.94	9.94	0.40	0.40	33.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	211.45	90.54	52.86	8.51	6.08	0.00	0.61	29.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	197.83	108.60	62.25	8.30	8.30	0.00	0.00	22.83
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	146.30	101.46	59.66	15.96	12.92	0.00	0.38	28.88
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	198.30	99.15	63.52	11.88	12.39	0.00	2.07	26.85
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	204.98	119.12	52.00	3.63	11.49	0.00	0.60	22.98
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	171.44	107.75	63.06	10.14	12.36	0.32	0.32	26.62
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	184.45	117.28	73.03	12.26	8.00	0.53	1.60	30.92
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	210.90	106.31	78.73	8.62	9.77	0.00	1.15	20.69
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	150.67	104.39	53.99	11.31	11.83	0.51	0.51	36.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	198.06	96.20	61.54	5.66	12.73	0.71	0.00	29.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	204.30	132.79	62.99	7.38	12.48	0.00	0.00	28.37
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	154.35	100.68	60.74	11.65	9.98	0.42	0.00	32.45
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	190.28	93.18	62.64	4.70	17.23	0.00	0.78	30.54
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	184.97	117.75	80.59	10.02	13.36	0.42	0.00	23.38
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	151.94	98.50	56.69	10.22	13.47	1.39	0.46	28.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	181.98	93.67	68.24	6.69	12.71	0.00	0.00	20.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	194.08	147.03	68.43	4.81	9.62	0.00	0.00	19.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	147.09	120.82	65.06	8.49	14.14	0.00	0.81	29.90
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	165.20	91.78	67.00	9.18	12.85	0.92	0.00	18.36
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	232.95	144.04	70.24	8.00	11.56	0.00	0.00	16.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	145.32	105.43	71.23	9.12	12.54	0.00	0.57	25.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	187.12	110.43	62.12	9.97	13.04	0.00	0.00	20.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	256.08	165.79	96.85	3.28	10.94	0.00	0.00	20.25
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	142.99	113.14	64.59	13.36	10.25	0.00	0.45	26.28
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	159.35	110.22	51.99	11.18	16.12	0.00	0.00	20.80
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	248.00	163.79	90.85	3.32	11.27	0.00	0.00	33.16
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	170.45	128.87	85.22	20.79	6.24	0.00	0.00	24.94
Macrophage - monocyte derived, donor1	11232-116C8	80.91	38.06	21.42	11.17	11.40	0.00	0.23	9.34
Macrophage - monocyte derived, donor2	11313-117C8	80.19	29.18	19.64	6.97	4.95	0.00	0.18	3.49
Macrophage - monocyte derived, donor3	11389-118C3	74.59	44.17	29.89	12.06	11.01	0.00	0.26	11.67
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	73.81	43.01	25.49	14.34	11.15	0.00	0.00	6.90
Mallassez-derived cells, donor2	11929-125I3	70.35	22.50	27.25	6.65	9.82	0.00	0.00	5.55
Mallassez-derived cells, donor3	11930-125I4	100.77	39.33	33.36	12.65	13.06	0.00	0.00	8.34
Mammary Epithelial Cell, donor1	11273-116H4	69.25	64.67	38.56	20.93	17.94	0.00	0.10	13.95
Mammary Epithelial Cell, donor2	11350-117G9	79.63	47.49	30.98	18.82	20.85	0.00	0.29	16.50
Mammary Epithelial Cell, donor3	11422-118F9	63.60	33.17	21.95	9.73	5.49	0.00	0.00	10.23
Mast cell - stimulated, donor1	11487-119E2	139.65	54.23	44.74	17.63	18.98	0.00	0.68	10.85
Mast cell, donor1	11563-120D6	81.75	21.95	17.84	11.25	9.84	0.11	0.32	6.81
Mast cell, donor2	11565-120D8	190.49	42.50	35.36	8.62	8.92	0.30	0.30	8.32
Mast cell, donor3	11566-120D9	267.00	44.12	42.10	10.58	16.21	0.23	0.68	14.63
Mast cell, donor4	11567-120E1	257.25	53.72	40.95	8.51	7.45	1.24	1.06	10.64
Mast cell, expanded and stimulated, donor5	11940-126A5	147.04	31.27	33.38	15.30	12.42	0.22	0.22	8.98
Mast cell, expanded and stimulated, donor8	11942-126A7	216.55	40.27	40.27	12.84	8.76	0.00	0.00	2.92
Mast cell, expanded, donor5	11939-126A4	101.76	23.40	25.35	11.01	11.24	0.11	0.11	5.74
Mast cell, expanded, donor8	11941-126A6	121.34	32.97	22.93	9.04	7.53	0.17	0.67	8.87
Melanocyte - dark, donor1	11502-119F8	155.52	33.43	35.42	16.22	13.43	0.10	0.00	9.75
Melanocyte - dark, donor2	11582-120F7	97.25	20.76	28.38	10.04	7.61	0.00	0.00	8.65
Melanocyte - dark, donor3	11663-122F7	99.68	41.51	30.06	15.57	14.27	0.07	0.14	11.66
Melanocyte - light, donor1	11274-116H5	84.16	23.04	15.51	2.59	3.53	0.00	0.00	4.00
Melanocyte - light, donor2	11351-117H1	43.00	8.19	7.51	2.73	2.05	0.00	0.00	4.09
Melanocyte - light, donor3	11423-118G1	47.70	15.61	18.21	5.20	5.20	0.00	0.00	6.94
Melanocyte, donor1 (MC+1)	12641-134G4	156.60	57.58	57.48	14.06	10.72	0.10	0.21	13.64
Melanocyte, donor2 (MC+2)	12739-135I3	153.30	49.49	43.57	9.41	9.14	0.00	0.00	6.99
Melanocyte, donor3 (MC+3)	12837-137B2	136.87	23.30	36.96	5.89	6.96	0.00	0.00	9.64
Meningeal Cells, donor1	11493-119E8	284.97	49.13	47.76	6.95	25.43	0.12	0.00	7.57
Meningeal Cells, donor2	11573-120E7	224.92	57.22	60.74	8.80	18.93	0.00	0.00	12.76
Meningeal Cells, donor3	11654-122E7	228.12	73.43	61.94	23.39	24.78	0.08	0.00	15.40
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	155.12	59.31	38.78	25.38	16.54	0.00	0.00	17.96
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	52.53	15.20	13.28	4.73	3.32	0.00	0.00	4.03
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	1.31	0.00	1.31	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	66.72	17.01	24.86	11.77	6.54	0.00	0.00	7.85
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	165.05	72.48	69.61	15.07	13.63	0.00	0.00	15.07
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	63.32	14.82	14.82	6.56	8.47	0.00	0.21	5.51
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	93.49	33.17	24.13	7.54	12.06	0.00	0.00	9.05
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	153.61	32.52	37.80	12.97	14.50	0.00	0.00	10.33
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	204.56	72.33	54.79	14.61	21.92	0.00	0.00	14.61
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	163.07	54.83	49.72	12.48	17.80	0.00	0.00	10.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	116.21	22.72	16.07	6.51	9.70	0.00	0.00	6.93
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	53.90	5.95	9.29	3.35	4.09	0.00	0.00	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	106.44	23.55	22.10	12.24	15.92	0.00	0.13	8.82
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	46.88	5.34	4.75	2.08	2.97	0.00	0.00	3.86
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	11.68	4.67	7.01	0.00	0.00	0.00	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	153.70	60.84	49.31	10.25	15.37	0.00	0.00	9.61
Mesenchymal stem cells - adipose, donor0	11217-116B2	161.63	80.46	54.94	25.17	24.46	0.00	0.00	15.60
Mesenchymal stem cells - hepatic, donor0	11218-116B3	79.74	24.71	20.33	12.20	13.76	0.00	0.00	8.76
Mesenchymal stem cells - umbilical, donor0	11214-116A8	203.19	69.67	76.92	12.34	23.95	0.00	0.00	17.42
Mesothelial Cells, donor1	11247-116E5	84.86	25.72	23.60	7.16	2.92	0.00	0.00	4.24
Mesothelial Cells, donor2	12156-128G5	84.58	28.03	27.03	4.50	4.50	0.00	0.00	3.50
Mesothelial Cells, donor3	11402-118D7	89.17	34.47	24.86	7.37	5.78	0.07	0.00	6.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	85.07	21.61	24.31	2.70	2.70	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	103.68	28.81	22.66	7.63	7.14	0.00	0.25	5.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	90.99	29.15	24.44	4.71	5.30	0.00	0.00	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	114.08	58.77	34.57	3.46	3.46	0.00	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	75.32	27.28	16.74	7.44	8.37	0.00	0.31	5.58
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	71.98	23.44	17.42	3.53	2.70	0.00	0.21	3.53
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	85.69	37.06	18.53	2.32	4.63	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	81.34	27.28	14.52	8.76	6.01	0.00	0.00	4.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	107.06	29.33	27.00	4.19	7.45	0.00	0.00	5.12
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	155.73	38.93	19.47	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	71.53	28.25	19.51	5.69	8.74	0.00	0.00	5.69
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	89.49	25.34	18.61	1.98	3.96	0.00	0.00	5.15
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	85.51	34.21	8.55	8.55	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	64.60	28.32	15.93	2.65	2.65	0.00	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	75.99	28.12	20.14	2.28	3.04	0.00	0.00	3.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	69.74	36.85	22.37	9.21	3.95	0.00	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	67.70	23.34	15.49	5.73	5.73	0.00	0.00	2.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	104.97	35.91	17.50	5.52	4.60	0.00	0.00	4.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	78.98	24.14	19.08	6.86	3.87	0.00	0.30	5.66
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	114.01	40.24	36.89	1.68	0.00	0.00	0.00	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	33.95	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	52.94	17.81	15.81	4.01	4.52	0.00	0.00	4.52
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	70.11	21.15	15.45	2.61	2.85	0.00	0.00	2.85
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	41.47	16.59	6.08	6.08	2.76	0.00	0.00	4.98
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	34.77	8.98	11.28	3.45	3.91	0.00	0.00	3.22
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	54.48	15.78	10.94	3.37	3.37	0.00	0.00	1.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	53.20	16.31	15.90	3.06	4.89	0.00	0.00	2.45
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	40.98	13.73	10.08	3.65	4.51	0.00	0.00	3.65
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	56.68	20.90	19.12	2.67	3.33	0.00	0.00	2.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	72.23	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	37.45	9.20	7.88	3.72	1.97	0.00	0.00	2.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	59.31	28.90	15.21	0.51	1.52	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	59.65	24.85	14.91	3.31	1.66	0.00	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	44.30	13.86	18.21	4.08	5.44	0.00	0.00	3.81
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	77.64	24.11	18.53	2.94	2.94	0.00	0.00	1.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	56.70	30.53	17.45	2.18	4.36	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	51.90	13.46	9.13	4.81	0.96	0.00	0.00	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	54.03	17.21	16.01	3.60	3.60	0.00	0.40	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	56.22	56.22	31.54	9.60	5.48	0.00	0.00	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	45.55	16.02	17.02	4.00	5.51	0.00	0.00	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	73.39	69.31	22.42	2.04	8.15	0.00	0.00	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	62.18	26.71	24.96	5.69	6.13	0.00	0.88	4.38
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	70.63	48.56	24.28	3.31	1.10	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	75.57	65.32	33.94	13.45	5.12	0.00	0.00	12.81
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	60.24	22.56	19.83	7.19	4.96	0.00	0.00	7.19
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	48.71	34.79	18.09	6.96	4.18	0.70	0.00	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	97.23	83.98	53.04	8.84	8.84	0.00	0.00	15.47
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	38.97	27.01	21.20	6.84	6.15	0.00	0.00	5.13
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	66.96	40.70	31.95	6.13	4.81	0.00	0.00	7.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	58.95	60.01	41.90	7.81	5.33	0.36	0.71	10.30
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	50.22	27.77	25.25	6.45	4.77	0.00	0.00	6.45
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	44.06	28.68	17.87	2.91	5.82	0.00	0.00	7.07
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	65.85	85.66	37.88	11.65	12.24	0.00	0.00	20.40
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	54.90	28.66	28.05	5.73	7.54	0.00	0.00	4.52
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	54.68	25.46	20.45	5.01	6.26	0.00	0.00	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	86.63	43.31	7.22	7.22	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	59.11	39.71	29.55	8.31	4.62	0.00	0.00	9.24
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	85.94	60.90	40.41	7.40	7.97	0.00	0.00	9.11
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	63.56	41.18	34.55	8.57	7.60	0.00	0.00	8.01
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	56.24	31.36	22.03	5.18	6.22	0.00	0.26	6.74
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	102.53	51.48	40.75	7.29	5.15	0.00	0.00	7.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	76.22	75.59	33.03	6.35	8.89	0.00	0.00	11.43
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	61.12	35.23	27.22	5.34	5.34	0.27	0.00	6.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	84.11	38.31	25.74	4.49	6.59	0.00	0.00	7.18
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	63.42	30.93	21.89	6.07	5.65	0.00	0.00	5.65
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	64.02	30.26	28.98	5.41	5.10	0.00	0.00	3.82
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	79.61	49.53	28.97	5.97	5.97	0.00	0.00	8.40
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	70.53	54.98	30.34	11.00	6.45	0.00	0.00	10.24
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	61.94	26.42	31.25	6.25	5.68	0.00	0.28	6.53
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	71.04	31.71	27.53	2.21	4.92	0.00	0.00	6.88
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	65.82	44.97	22.16	11.73	6.52	0.00	0.00	12.38
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	71.74	25.87	24.99	6.47	5.00	0.00	0.00	4.41
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	87.07	28.54	23.64	4.61	4.61	0.00	0.00	4.90
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	78.31	24.73	16.90	4.12	7.83	0.00	0.00	6.18
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	70.57	25.01	19.65	4.76	6.25	0.00	0.00	4.47
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	11.30	11.30	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	64.16	21.39	23.17	10.69	1.78	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	82.47	33.19	24.97	9.86	12.49	0.00	0.00	10.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	77.84	18.94	19.99	7.36	8.42	0.00	1.05	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	81.05	20.76	19.37	7.12	10.48	0.00	0.00	5.34
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	110.83	19.56	30.73	8.38	5.59	0.00	0.00	11.18
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	87.87	35.68	28.54	9.01	8.64	0.00	0.38	8.64
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	84.16	22.37	19.18	6.92	4.26	0.00	0.00	5.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	68.31	23.19	15.72	9.61	11.99	0.00	0.00	4.98
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	70.73	13.26	15.47	4.42	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	87.21	34.08	28.21	7.69	8.43	0.00	0.00	8.43
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	77.78	26.45	23.33	6.22	12.44	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	108.49	17.10	26.72	22.45	13.90	0.00	0.00	4.28
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	27.05	19.32	0.00	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	70.70	34.34	34.34	10.10	5.05	0.00	0.00	10.10
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	88.12	24.03	24.88	3.79	10.12	0.00	0.00	7.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	102.15	34.05	25.88	19.07	14.98	0.00	0.00	9.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	57.22	17.17	29.25	7.63	8.27	0.00	0.00	5.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	70.46	21.87	28.34	9.72	13.77	0.00	0.00	12.15
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	89.12	61.93	33.23	10.57	9.06	0.00	0.00	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	199.86	137.04	85.65	22.84	22.84	0.00	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	179.43	205.53	185.96	13.05	13.05	0.00	0.00	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	85.54	38.02	28.51	28.51	9.50	0.00	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	87.84	50.20	0.00	12.55	0.00	0.00	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	66.57	24.99	20.25	8.19	9.05	0.00	0.00	6.03
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	84.14	23.52	26.13	7.84	7.32	0.00	0.00	5.75
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	204.92	119.48	106.80	10.68	13.35	0.00	0.00	22.69
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	108.10	118.95	69.28	16.28	8.35	0.00	0.00	11.27
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	245.28	233.11	137.85	22.06	18.82	0.38	0.00	22.82
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	146.82	98.94	97.35	25.53	14.36	0.00	0.00	23.94
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	117.63	62.55	48.28	7.48	7.48	0.00	0.00	13.60
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	119.45	73.51	64.32	29.40	22.05	1.84	1.84	14.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	102.12	44.36	39.76	10.46	11.30	0.00	0.00	9.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	107.15	92.74	55.79	14.18	15.34	0.00	0.00	19.52
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	155.38	53.78	66.75	8.92	11.08	0.00	0.00	16.75
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	117.31	41.63	40.79	8.62	7.57	0.00	0.21	8.20
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	189.29	100.21	100.21	55.67	44.54	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	123.10	40.70	38.72	9.43	12.41	0.00	0.00	13.40
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	95.82	48.72	38.16	7.58	6.77	0.27	0.00	11.37
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	94.53	34.23	29.92	9.29	7.48	0.00	0.00	14.05
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	110.56	50.95	40.99	16.66	15.02	0.00	0.00	21.39
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	101.70	26.06	29.53	8.02	8.57	0.00	0.00	8.75
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	138.44	36.07	49.86	7.96	12.20	0.00	0.00	14.32
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	141.67	48.02	47.42	9.60	12.01	0.00	0.00	18.01
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	207.41	63.34	69.57	8.20	9.52	0.00	0.00	9.52
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	73.51	34.80	30.90	11.55	8.78	0.00	0.00	17.89
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	119.06	36.86	45.68	7.76	9.88	0.00	0.00	10.05
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	109.70	36.57	43.60	9.14	5.63	0.00	0.00	12.66
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	144.81	43.21	45.97	17.01	9.65	0.00	0.00	16.09
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	130.14	36.63	39.85	7.39	12.85	0.00	0.00	15.42
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	99.33	53.46	33.11	10.00	6.90	0.00	0.00	8.28
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	118.84	75.85	32.87	27.81	30.34	2.53	0.00	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	109.16	33.19	34.31	7.35	6.24	0.00	0.22	6.68
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	131.67	46.57	43.19	10.16	9.31	0.42	0.00	13.97
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	111.79	66.22	52.45	15.43	8.07	0.00	0.00	16.61
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	132.64	43.78	57.09	13.31	10.73	0.43	0.00	15.02
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	216.67	27.08	36.11	36.11	18.06	0.00	0.00	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	209.60	49.98	51.98	7.00	10.66	0.00	0.00	10.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	119.48	41.03	49.14	3.61	2.71	0.00	0.00	7.21
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	129.75	43.25	57.54	8.33	9.52	0.00	0.00	9.13
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	145.80	41.79	52.93	9.29	6.50	0.00	0.00	13.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	110.86	45.40	34.05	11.35	7.57	0.00	0.00	13.24
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	115.36	42.04	49.21	5.87	6.84	0.00	0.00	12.06
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	173.88	52.29	61.88	7.41	11.33	0.00	0.00	17.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	104.93	37.99	41.16	6.78	5.88	0.00	0.45	7.24
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	137.58	42.33	62.62	5.29	8.82	0.00	0.00	13.23
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	122.33	39.23	49.86	11.30	5.98	0.00	0.00	8.64
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	188.99	44.64	56.55	11.41	9.42	0.00	0.00	17.36
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	108.72	40.58	38.67	6.89	7.27	0.00	0.00	12.63
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	85.59	26.92	22.99	15.73	10.28	0.00	0.60	10.89
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	115.15	26.96	35.14	6.41	8.40	0.22	0.00	5.97
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	134.18	44.05	47.44	8.81	6.78	0.00	0.00	8.81
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	20.44	61.31	35.77	30.66	0.00	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	174.37	35.36	42.07	7.32	6.71	0.00	0.00	8.54
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	112.68	44.69	41.55	7.24	3.46	0.00	0.00	8.50
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	145.58	35.41	44.79	12.41	7.87	0.00	0.00	13.01
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	112.34	15.03	26.11	5.54	4.75	0.00	0.79	5.54
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	132.64	56.68	39.68	7.94	6.80	0.00	1.13	11.34
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	121.39	70.81	80.93	10.12	15.17	5.06	5.06	15.17
Myoblast, donor1	11241-116D8	54.04	48.20	26.96	10.81	8.20	0.00	0.00	9.81
Myoblast, donor2	11322-117D8	81.70	41.04	35.86	16.11	11.12	0.00	0.19	11.89
Myoblast, donor3	11398-118D3	93.67	45.91	33.46	13.12	13.79	0.00	0.00	7.06
NK T cell leukemia cell line:KHYG-1	10777-110G3	174.54	83.04	59.39	21.31	22.77	0.44	0.29	23.79
Natural Killer Cells, donor1	11230-116C6	160.22	43.67	27.98	7.07	7.07	0.31	0.62	3.38
Natural Killer Cells, donor2	11311-117C6	177.01	48.25	31.06	6.94	6.03	0.60	3.02	4.52
Natural Killer Cells, donor3	11387-118C1	154.79	43.44	27.79	7.55	7.18	1.10	2.21	9.75
Neural stem cells, donor1	11275-116H6	385.44	58.07	64.60	17.42	19.60	0.36	0.00	7.26
Neural stem cells, donor2	11352-117H2	273.44	34.66	30.81	11.55	17.33	0.00	0.00	5.78
Neurons, donor1	11494-119E9	229.86	42.10	56.89	14.79	17.07	0.00	0.00	6.83
Neurons, donor2	11574-120E8	223.69	31.04	48.88	20.48	21.58	0.00	0.22	7.93
Neurons, donor3	11655-122E8	246.65	78.93	85.51	17.27	18.91	0.00	0.00	13.98
Neutrophils, donor1	11233-116C9	100.22	11.14	9.28	0.00	3.71	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	66.67	0.00	5.80	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	194.86	18.94	15.88	2.44	3.05	0.00	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	83.35	15.55	17.34	11.28	13.42	0.12	0.12	10.45
Nucleus Pulposus Cell, donor2	11409-118E5	80.42	15.30	16.61	10.74	3.91	0.33	0.00	9.44
Nucleus Pulposus Cell, donor3	11462-119B4	109.10	24.47	22.66	9.23	9.83	0.00	0.20	10.03
Olfactory epithelial cells, donor1	11933-125I7	79.43	40.61	35.10	9.50	4.40	0.00	0.00	11.84
Olfactory epithelial cells, donor2	11934-125I8	84.53	60.94	43.71	8.83	9.70	0.14	0.29	12.74
Olfactory epithelial cells, donor3	11935-125I9	87.29	43.59	39.95	7.26	7.95	0.00	0.00	11.69
Olfactory epithelial cells, donor4	11936-126A1	121.75	53.57	51.52	9.35	12.27	0.00	0.10	13.44
Oligodendrocyte - precursors, donor1	11496-119F2	128.79	45.14	40.32	18.66	15.05	0.00	0.60	10.83
Osteoblast - differentiated, donor1	11276-116H7	65.51	19.57	18.93	5.53	6.81	0.00	0.00	7.44
Osteoblast - differentiated, donor2	11353-117H3	42.30	11.43	12.57	4.57	2.29	0.00	0.00	6.86
Osteoblast - differentiated, donor3	11425-118G3	57.73	5.59	14.28	6.83	7.45	0.00	0.00	6.21
Osteoblast, donor1	11277-116H8	80.32	27.75	21.11	9.97	10.75	0.00	0.20	7.82
Osteoblast, donor2	11354-117H4	159.43	37.22	49.16	19.66	16.86	0.70	0.70	8.43
Osteoblast, donor3	11426-118G4	96.33	41.59	35.90	17.06	14.93	0.18	0.00	17.42
Pancreatic stromal cells, donor1	11249-116E7	97.97	36.98	28.39	13.73	15.84	0.00	0.17	8.93
Pericytes, donor1	11491-119E6	68.43	10.35	10.24	2.67	4.67	0.00	0.00	1.11
Pericytes, donor2	11571-120E5	94.17	14.26	13.58	2.49	5.21	0.23	0.00	2.94
Pericytes, donor3	11652-122E5	86.47	46.39	32.55	10.78	12.21	0.20	0.20	7.32
Perineurial Cells, donor1	11499-119F5	117.09	41.37	31.76	16.95	17.86	0.11	0.00	11.08
Perineurial Cells, donor2	11579-120F4	118.88	25.58	26.68	11.59	9.75	0.00	0.09	8.93
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	214.51	37.61	28.37	13.39	14.98	0.64	0.96	12.43
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	124.88	33.30	20.81	11.02	8.08	0.49	0.73	8.33
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	143.00	38.31	27.18	9.58	9.32	0.26	0.39	13.20
Placental Epithelial Cells, donor1	11278-116H9	67.44	14.11	14.35	6.70	6.46	0.00	0.00	3.83
Placental Epithelial Cells, donor2	11355-117H5	79.84	6.65	19.96	3.33	5.54	0.00	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	73.03	10.60	16.49	5.89	6.28	0.00	0.00	4.91
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	68.35	21.84	25.63	3.48	4.75	0.00	0.00	4.43
Preadipocyte - breast, donor1	11467-119B9	81.79	19.32	21.38	6.00	6.38	0.00	0.19	3.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.34	18.40	17.62	5.22	5.35	0.00	0.13	1.96
Preadipocyte - breast, donor2	11328-117E5	72.72	24.09	21.39	8.33	8.56	0.23	0.23	5.63
Preadipocyte - omental, donor1	11468-119C1	88.34	23.87	26.85	7.03	8.74	0.11	0.00	2.66
Preadipocyte - omental, donor2	11329-117E6	84.24	22.26	25.75	4.80	7.42	0.00	0.00	3.49
Preadipocyte - omental, donor3	11403-118D8	84.09	34.38	30.80	8.88	8.02	0.00	0.00	6.73
Preadipocyte - perirenal, donor1	11469-119C2	65.95	10.83	22.64	6.89	4.92	0.00	0.00	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	53.13	27.95	17.51	8.91	8.91	0.00	0.00	5.84
Preadipocyte - subcutaneous, donor2	11356-117H6	190.89	86.41	63.75	23.55	21.78	0.00	0.00	18.42
Preadipocyte - subcutaneous, donor3	11428-118G6	106.09	49.89	33.89	17.54	13.62	0.17	0.00	13.96
Preadipocyte - visceral, donor1	11280-116I2	160.96	60.83	44.24	20.86	20.40	0.09	0.09	10.53
Preadipocyte - visceral, donor2	11357-117H7	186.83	57.06	53.38	10.58	14.73	0.00	0.00	8.28
Preadipocyte - visceral, donor3	11429-118G7	106.68	55.17	41.80	14.94	18.39	0.10	0.10	12.43
Prostate Epithelial Cells (polarized), donor1	11253-116F2	177.40	70.75	39.83	12.07	14.48	0.15	0.15	12.82
Prostate Epithelial Cells, donor2	11331-117E8	81.93	62.02	35.48	9.48	5.42	0.00	0.14	10.70
Prostate Epithelial Cells, donor3	11404-118D9	131.17	45.56	46.79	7.10	5.70	0.06	0.24	12.43
Prostate Stromal Cells, donor1	11254-116F3	100.92	52.74	36.22	17.77	18.68	0.00	0.11	9.68
Prostate Stromal Cells, donor2	11332-117E9	154.20	66.88	46.98	13.09	14.88	0.18	0.00	11.65
Prostate Stromal Cells, donor3	11405-118E1	77.16	24.71	21.38	10.53	7.61	0.21	0.00	7.30
Renal Cortical Epithelial Cells, donor1	11516-119H4	144.17	22.99	29.20	4.01	6.20	0.36	0.00	6.93
Renal Cortical Epithelial Cells, donor2	11596-120H3	186.38	69.59	56.00	10.81	10.54	0.00	0.00	10.60
Renal Epithelial Cells, donor1	11517-119H5	126.81	24.35	26.38	5.58	9.64	0.00	0.00	4.57
Renal Epithelial Cells, donor2	11597-120H4	179.96	42.68	39.83	9.25	10.67	0.00	0.00	13.52
Renal Epithelial Cells, donor3	11678-122H4	208.55	63.10	55.37	10.16	12.07	0.00	0.11	9.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	221.96	28.60	25.87	4.09	6.13	0.00	0.00	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	208.75	51.21	46.76	7.14	10.92	0.00	0.13	11.19
Renal Glomerular Endothelial Cells, donor3	11675-122H1	224.23	81.03	78.37	14.43	16.43	0.22	0.00	13.54
Renal Glomerular Endothelial Cells, donor4	11783-124B1	97.15	14.64	14.64	2.00	3.99	0.00	0.00	4.66
Renal Mesangial Cells, donor1	11518-119H6	111.14	25.75	27.51	8.80	8.36	0.22	0.22	5.06
Renal Mesangial Cells, donor2	11598-120H5	157.37	32.60	23.83	5.02	11.91	0.00	0.00	3.13
Renal Mesangial Cells, donor3	11679-122H5	68.52	19.70	19.42	6.38	8.60	0.00	0.00	6.10
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	213.93	72.74	55.83	11.27	16.64	0.00	0.27	11.01
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	134.94	48.49	38.37	10.54	5.90	0.00	0.00	5.48
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	167.97	61.71	51.49	14.08	13.50	0.00	0.19	13.88
Retinal Pigment Epithelial Cells, donor0	11215-116A9	170.87	68.97	40.71	17.89	21.78	0.00	0.00	14.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	112.28	14.78	23.02	4.55	7.96	0.00	0.00	7.96
Retinal Pigment Epithelial Cells, donor2	11608-120I6	135.84	27.79	43.22	7.20	10.29	0.00	0.00	9.26
Retinal Pigment Epithelial Cells, donor3	11689-122I6	188.93	20.57	24.09	6.02	4.01	0.00	0.00	4.27
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	609.91	86.86	96.35	6.95	11.63	1.60	2.27	12.29
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	92.02	50.92	44.67	13.40	8.93	0.89	0.00	16.97
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	204.19	52.84	56.14	8.81	9.91	0.00	1.10	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	120.07	47.56	52.78	13.92	15.08	0.00	0.00	12.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	192.57	85.30	55.91	20.41	26.53	0.13	0.13	14.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	137.04	107.45	72.10	23.44	25.92	0.30	0.30	19.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	128.49	81.20	51.31	25.54	32.46	0.33	0.56	14.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	169.57	99.98	56.81	24.06	31.76	0.00	0.25	15.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	145.80	108.50	74.59	23.89	27.74	0.12	0.00	22.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	163.64	127.82	68.65	27.04	35.59	0.46	0.23	18.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	202.90	93.37	73.79	16.02	17.52	0.00	0.14	20.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	129.94	98.78	65.65	22.54	24.20	0.30	0.15	18.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	128.48	74.36	49.64	22.58	28.85	0.00	0.18	15.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	203.99	86.36	71.15	13.34	24.10	0.29	0.57	20.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	137.79	95.72	65.46	22.64	26.94	0.32	0.11	19.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	147.14	107.76	67.49	23.01	24.34	1.11	1.11	20.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	245.09	76.85	76.09	13.76	16.63	0.00	0.38	25.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	149.99	117.01	69.41	27.20	27.20	0.19	0.19	19.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	183.21	77.42	59.57	21.80	19.35	0.19	0.19	13.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	244.05	127.53	82.41	22.69	23.62	0.27	0.40	22.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	134.43	103.18	72.81	24.63	24.34	0.00	0.10	21.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	158.88	116.48	70.27	24.06	30.74	0.57	0.76	19.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	216.58	103.16	67.28	15.59	26.06	0.00	0.11	21.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	125.86	96.99	67.55	26.63	22.70	0.00	0.28	17.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	153.12	99.63	65.45	20.34	22.90	0.17	0.68	17.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	233.93	119.43	86.61	20.42	27.35	0.00	0.00	23.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	133.42	96.76	66.59	20.97	27.59	0.25	0.12	23.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	139.56	101.68	65.41	24.85	24.18	0.27	0.94	21.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	288.00	81.14	71.47	14.62	15.57	0.00	0.00	21.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	160.71	107.94	72.02	26.39	27.58	0.00	0.40	18.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	140.78	100.09	67.11	23.38	23.62	0.47	0.47	17.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	210.47	81.28	67.81	16.80	15.14	0.21	0.41	20.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	164.80	99.77	60.61	24.55	32.30	0.44	0.66	19.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	158.54	123.87	74.78	24.86	26.11	0.00	0.21	20.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	225.43	110.09	83.31	18.71	25.44	0.40	0.40	20.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	159.23	127.89	77.82	29.80	35.08	0.00	0.51	24.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	166.19	117.80	74.23	22.17	25.83	0.39	0.39	18.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	251.54	84.08	77.72	15.30	16.16	0.17	0.17	30.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	141.56	118.79	68.58	28.12	27.71	0.14	0.14	24.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	160.23	116.23	66.65	23.64	29.55	0.16	0.99	21.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	231.44	75.84	68.00	10.91	15.17	0.00	0.17	17.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	112.00	88.03	57.56	27.08	21.01	0.00	0.59	19.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	154.07	91.69	76.23	18.66	20.52	0.00	0.27	17.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	185.28	57.80	58.35	14.10	21.15	0.00	0.00	15.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	124.53	79.29	51.91	23.10	27.86	0.00	0.24	20.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	182.19	106.01	81.42	21.77	23.18	0.20	0.20	21.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	169.70	54.34	46.80	12.62	19.68	0.09	0.00	13.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	120.53	68.48	58.34	20.26	19.21	0.00	0.00	15.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	108.19	57.72	45.63	10.28	12.69	0.30	0.30	14.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	198.51	74.90	56.42	15.30	23.87	0.24	0.00	14.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	124.01	50.22	37.55	22.27	24.02	0.87	1.02	12.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	93.70	57.80	41.37	13.99	12.17	0.00	0.61	12.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	194.10	69.62	61.79	13.86	20.19	0.30	0.00	17.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	137.30	66.27	45.92	12.89	18.77	0.23	1.13	13.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	119.22	62.30	46.43	19.77	15.58	0.00	1.50	19.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	149.95	53.84	41.68	11.34	15.94	0.12	0.47	8.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	78.76	49.52	26.25	14.09	13.23	0.64	0.21	10.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	72.72	40.27	28.25	11.42	10.82	0.60	0.60	10.22
Schwann Cells, donor1	11498-119F4	173.78	46.45	38.18	9.78	17.49	0.00	0.00	7.71
Schwann Cells, donor2	11578-120F3	132.69	40.83	44.23	10.21	20.41	0.00	0.00	10.21
Schwann Cells, donor3	11659-122F3	139.12	53.02	39.87	13.58	12.93	0.00	0.00	10.52
Sebocyte, donor1	11220-116B5	118.32	51.49	41.63	12.05	10.96	0.00	0.00	9.86
Sebocyte, donor2	11301-117B5	125.00	77.21	63.88	10.57	13.33	0.00	0.00	16.54
Sebocyte, donor3	11378-118B1	99.76	36.28	38.13	5.36	5.77	0.00	0.00	9.28
Sertoli Cells, donor1	11255-116F4	92.77	51.35	33.13	31.48	13.25	0.00	0.00	8.28
Sertoli Cells, donor2	11333-117F1	175.11	59.31	39.54	11.30	5.65	0.00	0.00	8.47
Skeletal Muscle Cells, donor1	11281-116I3	102.93	17.33	19.09	9.15	12.05	0.00	0.18	5.81
Skeletal Muscle Cells, donor2	11358-117H8	34.70	4.34	7.23	0.72	2.89	0.00	0.00	2.89
Skeletal Muscle Cells, donor3	11430-118G8	116.21	45.15	20.90	14.21	25.08	0.00	0.00	10.87
Skeletal Muscle Cells, donor4	11451-119A2	172.80	79.80	55.93	16.02	20.11	0.00	0.00	12.88
Skeletal Muscle Cells, donor5	11455-119A6	181.64	79.23	57.97	13.23	20.51	0.15	0.30	15.16
Skeletal Muscle Cells, donor6	11459-119B1	214.69	100.96	66.95	16.16	23.39	0.00	0.15	18.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	129.28	33.52	29.74	16.13	14.24	0.13	0.13	16.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	152.82	37.24	36.24	15.98	14.41	0.14	0.29	16.84
Skeletal Muscle Satellite Cells, donor3	11397-118D2	192.17	81.55	68.85	25.20	21.33	0.10	0.10	18.95
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	128.32	24.10	31.34	9.01	11.63	0.00	0.25	5.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	62.24	29.67	18.82	14.48	13.03	0.00	0.00	8.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	77.06	20.23	19.26	6.33	7.16	0.00	0.00	4.13
Skin - palm, donor1	10286-104F7	80.58	56.41	13.43	21.49	13.43	0.00	0.00	26.86
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	116.33	59.54	53.91	8.51	8.79	0.00	0.00	19.89
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	170.12	13.09	51.53	2.45	2.45	0.00	0.00	13.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	147.22	56.73	52.84	10.26	9.87	0.00	0.00	15.71
Small Airway Epithelial Cells, donor1	11256-116F5	81.88	47.40	34.47	10.43	13.48	0.00	0.14	11.68
Small Airway Epithelial Cells, donor2	11334-117F2	76.38	64.98	34.74	14.63	12.10	0.14	0.00	16.32
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	108.47	52.86	32.14	13.11	9.30	0.21	0.42	7.82
Small Airway Epithelial Cells, donor3	11406-118E2	116.92	73.68	50.59	12.29	10.34	0.15	0.00	15.44
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	141.02	31.78	38.57	4.32	6.17	0.00	0.00	13.89
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	96.71	28.46	24.01	5.11	4.89	0.00	0.00	5.34
Smooth Muscle Cells - Aortic, donor0	11210-116A4	44.67	23.51	17.05	12.34	11.76	0.00	0.00	6.47
Smooth Muscle Cells - Aortic, donor1	11283-116I5	86.41	38.89	40.22	8.62	8.40	0.00	0.00	6.41
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.98	19.69	14.96	5.91	7.09	0.00	0.00	6.69
Smooth Muscle Cells - Aortic, donor3	11432-118H1	57.94	23.18	17.00	11.59	8.50	0.00	0.00	5.41
Smooth Muscle Cells - Bladder, donor1	11519-119H7	122.09	11.01	20.02	7.01	10.01	0.00	0.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	65.07	25.28	23.29	9.58	8.52	0.00	0.00	8.92
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	84.45	41.45	34.36	15.29	15.96	0.00	0.00	12.19
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	70.03	67.47	32.14	12.29	10.11	0.00	0.13	13.83
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.72	21.49	17.26	9.77	11.40	0.00	0.00	7.49
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	54.04	20.97	13.88	7.09	7.38	0.00	0.00	2.95
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	62.64	20.79	17.23	7.69	4.56	0.00	0.00	6.41
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	93.70	17.57	19.68	6.02	10.25	0.00	0.00	4.55
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	119.95	18.27	26.79	10.66	10.66	0.00	0.00	10.96
Smooth Muscle Cells - Carotid, donor1	11285-116I7	61.37	22.23	17.43	10.36	15.91	0.00	0.00	5.56
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	30.60	48.97	0.00	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	73.91	48.16	28.13	6.68	17.17	0.00	0.00	11.44
Smooth Muscle Cells - Colonic, donor1	11239-116D6	77.28	19.76	18.88	9.73	10.91	0.00	0.00	6.78
Smooth Muscle Cells - Colonic, donor2	11320-117D6	102.02	32.50	28.63	10.12	9.47	0.00	0.22	7.75
Smooth Muscle Cells - Colonic, donor3	11396-118D1	100.34	36.53	28.65	14.59	13.64	0.00	0.10	11.55
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	42.85	21.50	17.32	6.34	6.03	0.00	0.15	3.56
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	30.18	19.40	11.86	4.31	7.55	0.00	0.00	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	75.31	36.16	17.63	5.08	8.97	0.00	0.00	7.17
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	97.98	21.17	19.80	8.88	10.92	0.00	0.00	4.10
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	96.36	20.97	19.79	15.00	14.61	0.00	0.16	14.53
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	96.21	47.00	33.51	8.35	9.26	0.00	0.00	6.44
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	110.59	65.99	37.55	11.38	8.87	0.00	0.00	8.42
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	59.17	21.74	18.72	2.42	5.43	0.00	0.00	5.43
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	256.98	119.22	82.92	37.09	34.97	0.00	0.00	24.37
Smooth Muscle Cells - Prostate, donor1	11257-116F6	107.73	39.28	24.77	10.39	14.38	0.00	0.27	7.32
Smooth Muscle Cells - Prostate, donor2	11335-117F3	102.30	44.58	29.18	14.40	11.65	0.00	0.25	11.02
Smooth Muscle Cells - Prostate, donor3	11465-119B7	42.87	11.16	12.18	6.60	7.86	0.00	0.00	3.55
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	96.80	44.63	26.99	14.62	13.12	0.15	0.00	8.74
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	57.76	13.50	16.50	15.00	7.50	0.00	0.00	7.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	376.03	160.23	140.85	7.75	16.80	0.00	0.00	14.21
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	77.67	31.16	28.83	7.44	16.74	0.00	0.00	6.98
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	68.66	35.85	32.82	8.08	7.57	0.00	0.00	11.61
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	77.09	54.22	32.28	7.83	8.46	0.00	0.00	12.22
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	61.36	8.85	7.37	3.83	3.83	0.00	0.00	3.54
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	196.52	77.56	54.40	24.83	25.08	0.00	0.08	15.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	106.05	19.62	25.69	9.81	11.21	0.00	0.00	5.61
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	59.44	30.80	19.29	9.64	10.51	0.00	0.00	6.19
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	92.04	46.91	33.65	13.51	10.45	0.25	0.00	10.45
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	84.99	41.93	29.52	9.40	13.54	0.00	0.19	7.90
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	172.03	55.48	46.40	20.26	19.28	0.00	0.00	15.23
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	92.50	26.90	19.94	10.39	11.06	0.00	0.00	6.45
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	57.14	4.76	4.76	1.90	5.24	0.00	0.00	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	57.01	31.56	24.47	13.21	12.97	0.00	0.24	6.36
Smooth Muscle Cells - Uterine, donor1	11258-116F7	111.14	44.19	29.61	7.29	10.61	0.00	0.22	5.97
Smooth Muscle Cells - Uterine, donor3	11466-119B8	82.21	34.23	24.87	13.75	10.53	0.00	0.00	7.31
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	94.26	11.66	27.79	5.83	7.00	0.00	0.00	6.80
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	44.96	30.15	23.27	3.97	6.88	0.00	0.00	4.76
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	110.10	14.88	26.04	1.86	3.35	0.00	0.00	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	81.21	21.56	27.67	5.03	5.39	0.36	0.00	6.83
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	56.78	18.74	19.59	4.83	4.26	0.00	0.00	3.69
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	125.25	39.39	53.57	9.45	15.75	0.00	0.00	15.75
Smooth muscle cells - airway, control, donor1	11966-126D4	69.07	18.54	24.38	5.59	5.59	0.25	0.00	9.65
Smooth muscle cells - airway, control, donor2	11967-126D5	127.38	22.76	26.36	6.39	6.79	0.00	0.00	7.99
Smooth muscle cells - airway, control, donor3	11968-126D6	90.71	15.47	23.41	2.09	2.93	0.00	0.00	6.69
Smooth muscle cells - airway, control, donor4	11969-126D7	101.76	12.83	19.25	4.13	7.33	0.46	0.00	5.96
Synoviocyte, donor1	11291-117A4	111.43	31.14	29.62	9.76	11.61	0.17	0.17	6.40
Synoviocyte, donor2	11368-117I9	84.32	27.99	24.64	12.24	8.05	0.00	0.17	10.56
Synoviocyte, donor3	11440-118H9	116.17	31.95	28.37	9.38	8.27	0.00	0.00	8.71
Trabecular Meshwork Cells, donor1	11532-120A2	215.83	46.81	57.53	12.86	22.15	0.00	0.00	11.79
Trabecular Meshwork Cells, donor2	11612-122A1	71.35	25.77	19.82	13.87	11.89	0.00	0.00	7.93
Trabecular Meshwork Cells, donor3	11693-123A1	99.80	25.24	25.01	9.96	13.20	0.00	0.23	8.34
Tracheal Epithelial Cells, donor1	11292-117A5	58.49	30.97	21.79	8.39	9.46	0.07	0.07	6.45
Tracheal Epithelial Cells, donor2	11369-118A1	48.71	25.13	18.94	8.12	8.12	0.00	0.00	7.34
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	20.04	20.04	10.31	10.88	0.00	0.00	4.58
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	618.69	77.26	93.01	7.26	11.20	1.72	2.83	10.33
Urethra, donor2	10319-105A4	320.12	62.94	39.57	12.59	5.40	0.00	0.00	10.79
Urothelial Cells, donor1	11520-119H8	64.29	19.13	22.32	6.38	7.97	0.00	0.00	6.11
Urothelial Cells, donor2	11600-120H7	65.69	22.43	20.03	5.61	6.41	0.00	0.00	6.41
Urothelial Cells, donor3	11681-122H7	68.53	29.11	22.69	4.58	7.33	0.00	0.00	6.19
Urothelial cells, donor0	11216-116B1	105.43	25.86	26.08	11.37	11.14	0.00	0.00	9.81
Whole blood (ribopure), donor090309, donation1	12179-129A1	704.71	20.47	118.34	2.67	16.91	0.00	0.00	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	767.70	20.01	157.26	5.72	17.16	0.00	1.43	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	436.72	28.75	89.67	12.32	10.95	0.68	0.00	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	285.80	21.00	48.21	8.26	12.40	0.00	1.72	6.54
Whole blood (ribopure), donor090325, donation2	12177-128I8	307.94	15.11	47.64	7.55	13.94	0.00	0.58	4.65
Whole blood (ribopure), donor090612, donation1	12182-129A4	647.65	10.41	106.21	5.21	18.74	0.00	0.00	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	699.36	19.27	108.30	5.51	23.86	0.00	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	450.97	26.47	121.42	8.22	10.95	0.00	0.91	3.65
Wilms' tumor cell line:G-401	10809-111A8	158.40	99.92	61.93	25.91	19.86	0.25	0.25	32.57
Wilms' tumor cell line:HFWT	10597-108E3	127.61	29.04	32.56	5.28	9.68	0.88	0.00	5.28
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	189.94	133.23	72.06	25.98	27.37	0.28	0.56	27.37
achilles tendon, donor2	10292-104G4	142.59	43.40	68.20	8.27	8.27	0.00	0.00	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	292.18	63.99	55.07	13.00	14.53	0.51	0.76	10.96
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	230.78	75.69	52.70	44.35	39.93	0.93	0.70	27.40
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	243.94	91.17	63.75	30.03	35.97	0.83	0.95	20.89
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	235.65	114.56	92.25	36.74	24.76	0.00	0.54	21.77
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	163.59	74.21	55.37	12.93	18.27	0.00	0.00	10.96
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	168.97	108.28	73.81	38.91	29.82	0.21	0.00	21.99
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	177.21	59.61	37.84	15.79	18.78	0.00	1.36	24.23
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	217.23	96.94	77.11	24.24	22.03	0.00	0.88	31.29
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	169.47	86.16	62.07	35.94	42.06	0.00	1.23	36.34
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	126.20	83.10	51.64	39.99	30.68	0.00	1.55	35.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	238.65	139.66	78.94	41.77	40.66	0.74	0.37	40.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	97.51	85.81	42.91	31.20	27.30	0.00	0.00	42.91
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	191.02	92.72	65.30	31.60	29.74	0.00	0.00	24.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	316.12	177.09	120.91	34.43	36.25	0.52	1.04	38.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	253.38	155.47	87.97	35.36	36.24	0.88	0.29	33.61
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	171.50	115.26	70.64	35.79	27.89	0.00	0.46	34.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	189.18	48.94	41.95	20.15	34.55	0.00	0.00	20.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	306.64	200.13	126.46	47.58	30.08	0.00	0.31	71.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	167.27	113.93	52.49	26.03	24.32	0.00	0.43	23.04
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	139.52	86.74	34.58	28.81	29.42	0.00	0.30	20.62
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	178.36	102.78	43.81	36.11	31.53	0.00	0.00	25.51
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	190.22	86.65	77.96	26.73	20.71	0.22	0.67	19.60
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	236.82	111.74	108.40	20.68	23.68	0.00	0.00	27.35
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	501.71	267.58	250.86	18.58	22.30	0.00	0.00	24.16
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	290.41	103.58	130.32	25.61	23.73	0.38	1.51	17.70
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	196.26	65.42	64.11	27.48	20.50	0.00	0.00	27.91
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	101.22	59.98	76.85	31.87	22.49	0.00	1.87	20.62
adenocarcinoma cell line:IM95m	10796-110I4	118.22	129.05	67.82	32.26	27.08	0.00	0.00	35.56
adipose tissue, adult, pool1	10010-101C1	236.87	16.75	18.30	6.67	7.91	0.00	0.31	4.50
adipose, donor1	10184-103D4	228.11	50.43	31.67	29.91	16.42	0.00	0.59	15.83
adipose, donor2	10185-103D5	316.30	61.23	49.07	17.03	9.73	0.00	1.22	21.90
adipose, donor3	10186-103D6	268.48	52.82	55.27	16.61	5.72	0.54	1.09	14.16
adipose, donor4	10187-103D7	324.17	58.07	109.21	23.40	5.20	0.00	0.00	16.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	239.73	181.97	143.30	37.09	18.15	0.16	0.32	54.29
adrenal gland, adult, pool1	10081-102A9	192.80	69.12	58.20	0.00	18.19	0.00	0.00	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	99.25	74.84	41.36	28.55	27.08	0.13	1.07	16.94
alveolar cell carcinoma cell line:SW 1573	10708-109H6	255.11	203.66	89.68	38.95	35.73	0.00	0.00	48.95
amniotic membrane cells, donor1	12235-129G3	146.30	30.84	35.70	6.72	5.10	0.23	0.23	7.19
amniotic membrane cells, donor2	12236-129G4	158.91	30.43	32.46	7.78	6.76	0.00	0.00	7.78
amniotic membrane cells, donor3	12237-129G5	216.53	49.49	43.01	5.30	4.42	0.00	0.00	10.02
amygdala - adult, donor10196	10167-103B5	164.83	67.59	69.96	5.93	10.67	0.00	0.00	8.30
amygdala, adult, donor10252	10151-102I7	260.35	71.58	68.54	18.05	25.35	1.42	1.42	11.76
amygdala, newborn, donor10223	10360-105E9	353.11	81.66	96.51	8.39	9.68	0.00	0.32	8.71
anaplastic carcinoma cell line:8305C	10428-106D5	108.87	26.99	22.54	14.77	15.92	0.25	0.25	14.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	196.35	114.28	88.25	26.25	20.08	0.22	0.88	25.59
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	80.17	50.11	44.76	33.07	37.41	0.67	1.67	27.73
aorta, adult, pool1	10052-101G7	284.59	36.09	43.74	9.22	8.24	0.98	1.77	13.53
appendix, adult	10189-103D9	230.93	61.71	45.02	14.75	14.36	0.00	0.78	13.58
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	244.19	77.39	46.09	11.01	15.13	1.03	0.00	15.82
artery, adult	10190-103E1	175.27	31.25	24.46	8.15	8.15	0.00	0.00	6.79
astrocytoma cell line:TM-31	10425-106D2	133.57	23.76	20.57	17.38	21.44	0.14	0.14	8.26
b cell line:RPMI1788	10427-106D4	103.20	63.79	45.80	26.02	24.09	0.45	0.89	26.17
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.06	27.47	18.87	14.15	12.49	0.00	0.00	5.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	103.10	106.48	56.36	17.37	14.79	0.00	0.20	23.42
bile duct carcinoma cell line:TFK-1	10496-107C1	80.51	67.96	32.14	14.06	16.07	0.33	0.50	14.39
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	83.33	60.96	33.00	13.98	16.22	0.00	1.12	25.72
bladder, adult, pool1	10011-101C2	385.68	29.66	36.94	8.91	9.56	0.87	0.54	8.80
blood, adult, pool1	10053-101G8	294.55	37.65	68.65	28.79	17.72	0.00	0.00	13.29
bone marrow stromal cell line:StromaNKtert	10686-109F2	52.24	29.97	13.70	4.28	5.14	0.00	0.00	9.42
bone marrow, adult	10192-103E3	321.89	76.26	59.38	14.85	26.99	0.00	0.00	6.07
brain, adult, donor1	10084-102B3	168.11	58.43	46.13	13.33	9.23	0.00	0.00	8.20
brain, adult, pool1	10012-101C3	148.44	41.98	29.96	22.83	21.05	0.11	0.00	13.36
brain, fetal, pool1	10085-102B4	227.07	48.09	72.13	10.69	16.03	0.00	0.00	16.03
breast carcinoma cell line:MCF7	10482-107A5	228.94	149.66	89.86	14.54	11.23	0.00	0.66	40.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	92.99	76.77	33.70	14.98	13.23	0.12	0.37	16.48
breast, adult, donor1	10080-102A8	682.50	89.65	130.69	12.63	15.15	0.00	0.63	10.10
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	195.77	63.77	45.86	30.36	44.34	0.38	0.64	37.98
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	174.40	102.04	51.02	25.97	20.41	0.00	0.62	29.69
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	247.72	45.35	46.04	14.73	15.42	0.00	0.00	11.97
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	112.09	92.96	42.37	18.64	9.93	0.00	0.73	23.24
carcinoid cell line:NCI-H1770	10703-109H1	177.72	38.08	39.96	11.75	12.22	0.00	0.47	7.99
carcinoid cell line:NCI-H727	10735-110B6	254.75	109.60	86.30	23.08	25.16	0.11	0.22	33.58
carcinoid cell line:SK-PN-DW	10719-109I8	435.41	232.60	166.37	23.45	16.48	0.95	0.95	34.22
carcinosarcoma cell line:JHUCS-1	10642-109A3	339.11	79.05	76.66	25.82	30.08	0.00	1.06	25.82
caudate nucleus - adult, donor10196	10177-103C6	285.53	29.93	72.53	17.27	11.51	2.30	0.00	13.82
caudate nucleus, adult, donor10252	10164-103B2	228.40	62.58	58.56	19.24	17.57	0.84	2.01	16.90
caudate nucleus, adult, donor10258	10379-105H1	155.88	38.21	44.32	12.23	11.46	0.76	0.00	12.99
caudate nucleus, newborn, donor10223	10354-105E3	665.08	100.71	142.83	9.16	9.16	0.37	1.10	13.55
cerebellum - adult, donor10196	10173-103C2	259.28	61.18	93.22	5.83	32.05	0.00	0.00	23.31
cerebellum, adult, donor10252	10166-103B4	286.74	59.14	54.02	26.05	38.43	1.92	1.71	16.65
cerebellum, adult, pool1	10083-102B2	102.10	44.15	32.42	15.52	25.18	0.34	0.34	18.97
cerebellum, newborn, donor10223	10357-105E6	406.01	47.33	89.67	6.64	20.76	0.83	2.49	9.13
cerebral meninges, adult	10188-103D8	189.36	76.65	60.77	26.73	13.11	0.25	0.00	16.89
cerebrospinal fluid, donor2	10294-104G6	135.94	33.62	31.43	6.58	13.16	0.00	0.00	12.43
cervical cancer cell line:D98-AH2	10552-107I3	160.61	66.43	53.49	35.08	26.60	0.29	0.14	22.29
cervical cancer cell line:ME-180	10553-107I4	114.51	65.96	39.27	15.58	14.91	0.00	0.66	12.10
cervix, adult, pool1	10013-101C4	327.04	27.93	28.14	11.13	11.34	0.63	0.52	8.08
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	128.89	64.65	41.10	11.70	8.22	0.00	0.14	10.45
chondrosarcoma cell line:SW 1353	10700-109G7	58.78	48.33	23.51	1.31	6.53	0.00	0.00	3.92
choriocarcinoma cell line:BeWo	10423-106C9	302.86	110.73	71.58	33.18	24.86	0.37	1.12	33.93
choriocarcinoma cell line:SCH	10785-110H2	184.82	85.02	61.48	17.87	14.17	0.37	0.74	33.64
choriocarcinoma cell line:T3M-3	10618-108G6	196.62	54.31	52.65	9.01	4.27	0.00	0.71	19.45
chorionic membrane cells, donor1	12238-129G6	171.52	22.79	25.36	4.84	2.85	0.00	0.00	4.84
chorionic membrane cells, donor2	12239-129G7	121.31	27.14	25.35	11.04	12.23	0.10	0.30	5.97
chorionic membrane cells, donor3	12240-129G8	269.25	23.63	26.38	4.95	9.34	0.00	0.00	6.04
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	239.32	53.52	39.38	15.15	21.21	0.00	2.02	19.19
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	172.50	116.60	59.17	36.31	24.97	0.00	0.19	36.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	124.81	97.78	50.90	35.27	25.13	0.21	0.63	29.35
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	357.98	139.44	180.27	26.19	27.22	0.26	0.26	32.61
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	386.76	163.51	180.44	29.03	42.81	0.73	0.00	41.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	352.65	164.52	154.34	30.54	34.82	0.20	0.00	35.02
chronic myelogenous leukemia cell line:K562	10454-106G4	301.52	113.37	89.51	27.09	33.57	0.59	0.88	14.72
chronic myelogenous leukemia cell line:KU812	10409-106B4	214.49	99.82	73.50	31.01	24.76	0.26	1.04	13.55
clear cell carcinoma cell line:JHOC-5	10638-108I8	157.04	126.86	67.43	26.06	22.17	0.00	0.46	29.03
clear cell carcinoma cell line:TEN	10636-108I6	107.40	90.57	33.49	18.74	19.61	0.17	0.00	24.12
colon carcinoma cell line:CACO-2	10513-107D9	237.77	72.12	39.35	17.57	16.11	0.55	0.55	13.91
colon carcinoma cell line:COLO-320	10420-106C6	412.77	78.68	54.73	24.71	29.27	0.00	1.14	25.85
colon, adult, donor1	10082-102B1	240.39	63.07	52.36	19.04	29.75	0.00	0.00	16.66
colon, adult, pool1	10014-101C5	188.48	32.55	20.92	9.17	12.69	0.82	0.71	7.05
colon, fetal, donor1	10070-101I7	303.43	121.74	84.66	11.12	24.72	0.62	1.24	42.02
common myeloid progenitor CMP, donor1	12130-128D6	357.51	142.09	151.26	41.25	18.33	0.00	0.00	22.92
common myeloid progenitor CMP, donor2	12134-128E1	175.26	50.07	50.07	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	161.47	54.82	38.24	17.85	22.52	0.42	0.42	10.20
cord blood derived cell line:COBL-a 24h infection	10453-106G3	167.53	46.94	37.13	19.32	20.53	0.15	0.15	10.72
cord blood derived cell line:COBL-a untreated	10449-106F8	139.74	52.32	36.24	30.04	27.64	0.14	0.42	14.24
corpus callosum, adult, pool1	10042-101F6	273.09	30.74	37.37	13.82	14.59	1.00	0.77	8.84
cruciate ligament, donor2	10295-104G7	204.24	41.33	38.09	8.92	8.10	0.00	0.81	9.73
diaphragm, fetal, donor1	10069-101I6	195.83	36.92	40.93	4.82	13.64	0.00	0.80	6.42
diencephalon, adult	10193-103E4	173.75	37.20	41.52	14.40	12.00	0.24	0.24	9.84
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	214.23	103.78	70.26	41.10	43.40	0.46	1.38	28.01
ductal cell carcinoma cell line:KLM-1	10438-106E6	271.06	70.52	52.31	22.31	18.21	0.26	0.00	14.62
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	96.29	36.59	27.92	5.54	2.65	0.72	0.48	5.78
ductus deferens, adult	10196-103E7	241.20	58.80	43.85	12.96	11.46	0.50	1.99	7.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	211.71	70.57	72.01	11.52	23.04	0.00	1.44	17.28
duodenum, fetal, donor1, tech_rep2	10071-101I8	189.06	39.73	42.67	11.03	12.51	0.74	0.00	13.98
dura mater, adult, donor1	10041-101F5	75.82	26.59	15.53	16.52	15.20	0.25	0.17	10.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	158.34	79.28	58.85	6.44	9.77	0.00	0.22	7.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	317.40	119.51	83.97	12.04	15.33	0.00	1.00	11.32
embryonic pancreas cell line:1B2C6	10604-108F1	160.94	53.65	40.70	12.95	16.03	0.00	0.00	12.33
embryonic pancreas cell line:1C3D3	10605-108F2	139.55	62.36	29.97	16.35	16.35	0.00	0.61	16.95
embryonic pancreas cell line:1C3IKEI	10606-108F3	163.02	66.07	42.61	16.36	10.81	0.00	0.31	13.89
embryonic pancreas cell line:2C6	10603-108E9	127.41	45.97	38.09	19.70	21.02	0.00	0.00	14.45
endometrial carcinoma cell line:OMC-2	10497-107C2	408.94	81.45	65.70	11.73	12.40	0.00	0.00	10.06
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	141.00	30.09	29.72	11.78	15.95	0.18	0.00	15.95
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	134.92	50.01	40.20	6.27	4.82	0.00	0.16	9.97
epidermoid carcinoma cell line:A431	10426-106D3	118.72	134.95	82.37	16.90	17.67	0.11	0.11	18.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	136.60	142.98	90.52	26.18	25.30	0.22	0.11	24.53
epididymis, adult	10197-103E8	134.59	28.26	19.47	9.63	9.21	0.42	0.21	8.58
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	155.77	43.82	35.30	12.95	12.42	0.00	0.35	10.47
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	110.11	44.04	38.93	14.16	9.04	0.00	0.00	14.16
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	235.63	184.26	120.57	36.56	33.81	1.05	0.52	44.43
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	178.53	136.02	85.63	34.64	26.97	0.30	0.30	42.71
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	253.19	223.16	148.22	34.06	33.83	0.56	0.90	51.20
esophagus, adult, pool1	10015-101C6	200.99	38.33	33.66	9.13	10.94	0.00	0.53	7.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	241.83	32.69	46.71	6.76	8.27	0.38	0.25	8.89
eye - muscle inferior rectus, donor1	10272-104E2	222.14	41.05	36.22	12.07	12.07	0.00	4.83	7.24
eye - muscle lateral, donor2	10298-104H1	183.07	44.19	33.67	0.00	8.42	0.00	0.00	10.52
eye - muscle medial, donor2	10299-104H2	117.57	26.79	16.37	4.46	4.46	0.00	1.49	2.98
eye - muscle superior, donor2	10297-104G9	145.61	40.13	45.86	11.46	4.59	0.00	0.00	10.32
eye - vitreous humor, donor1	10268-104D7	68.50	46.64	43.72	11.66	11.66	0.00	0.00	24.78
eye, fetal, donor1	10054-101G9	199.83	28.47	40.68	8.64	16.78	0.51	0.25	10.93
fibrosarcoma cell line:HT-1080	10758-110E2	137.97	72.70	50.14	21.93	15.00	0.51	0.13	20.39
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	276.36	225.31	136.75	26.35	21.37	0.00	0.71	39.89
frontal lobe, adult, pool1	10040-101F4	132.10	35.18	27.02	18.39	18.48	0.47	0.38	10.32
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	231.49	132.71	81.07	18.01	17.71	0.30	1.20	19.22
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	120.42	54.13	28.62	23.32	21.76	0.18	0.00	13.99
gall bladder, adult	10198-103E9	154.76	39.35	27.76	9.17	8.45	0.24	0.72	7.73
gamma delta positive T cells, donor1	11937-126A2	206.15	28.99	46.71	12.88	8.59	0.00	0.00	5.37
gamma delta positive T cells, donor2	11938-126A3	145.66	41.08	38.10	7.84	10.83	0.00	0.75	6.35
gastric adenocarcinoma cell line:MKN1	10614-108G2	135.39	71.81	50.27	12.25	9.93	0.00	0.00	11.83
gastric adenocarcinoma cell line:MKN45	10612-108F9	163.44	68.47	53.58	18.95	18.37	0.00	0.39	21.47
gastric cancer cell line:AZ521	10549-107H9	187.73	58.53	50.33	18.85	14.76	0.16	0.16	13.94
gastric cancer cell line:GSS	10560-108A2	271.82	45.76	47.59	15.56	13.73	0.00	0.00	32.03
gastrointestinal carcinoma cell line:ECC12	10615-108G3	327.15	100.98	72.65	15.76	23.99	0.00	1.37	21.93
giant cell carcinoma cell line:LU65	10487-107B1	178.19	50.14	51.40	13.20	14.00	0.11	0.57	10.90
giant cell carcinoma cell line:Lu99B	10433-106E1	145.98	59.90	37.23	15.40	14.56	0.42	0.42	14.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	163.62	147.16	83.31	20.70	18.46	0.25	0.25	25.69
glioblastoma cell line:A172, tech_rep1	10444-106F3	103.44	42.85	30.72	13.72	11.93	0.00	0.00	9.92
glioblastoma cell line:A172, tech_rep2	10444-106F3	109.26	41.85	33.71	11.52	12.36	0.14	0.14	8.43
glioblastoma cell line:T98G	10485-107A8	132.78	41.17	27.48	15.45	15.56	0.11	0.22	8.17
glioma cell line:GI-1	10413-106B8	111.59	28.41	31.05	9.08	9.96	0.29	0.00	7.61
globus pallidus - adult, donor10196	10175-103C4	350.61	59.04	96.22	8.75	16.04	0.73	0.00	16.04
globus pallidus, adult, donor10252	10161-103A8	450.60	69.57	78.35	24.90	24.65	2.20	3.17	13.91
globus pallidus, adult, donor10258	10367-105F7	188.95	79.41	43.81	30.12	34.23	1.37	0.00	53.40
globus pallidus, newborn, donor10223	10364-105F4	360.25	53.29	71.94	9.06	5.86	0.00	0.53	6.93
granulocyte macrophage progenitor, donor1	12131-128D7	293.66	171.30	119.91	39.15	34.26	0.00	0.00	46.50
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	54.64	21.86	10.93	0.00	0.00	0.00	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	41.81	10.45	5.23	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	120.64	59.52	38.08	12.16	9.60	0.00	0.00	8.64
hIPS +CCl2, biol_rep1	14383-156B9	607.41	46.37	138.19	19.74	20.20	0.00	0.92	27.09
hIPS +CCl2, biol_rep2	14384-156C1	543.68	9.15	106.08	13.26	7.77	0.00	0.00	21.49
hIPS +CCl2, biol_rep3	14385-156C2	481.78	27.70	123.02	6.44	7.09	0.00	0.00	34.14
hIPS, biol_rep1	14380-156B6	504.49	17.25	38.81	2.87	4.31	0.00	0.00	34.49
hIPS, biol_rep2	14381-156B7	349.79	22.63	119.34	10.29	5.49	0.00	0.00	21.95
hIPS, biol_rep3	14382-156B8	179.87	11.03	58.48	7.72	3.31	0.00	0.00	7.72
hairy cell leukemia cell line:Mo	10712-109I1	111.20	71.26	45.97	31.03	21.55	0.00	0.57	19.54
heart - mitral valve, adult	10205-103F7	240.37	31.99	34.68	5.98	8.07	0.90	1.49	4.78
heart - pulmonic valve, adult	10206-103F8	202.12	16.47	18.83	5.23	9.67	0.00	0.26	6.28
heart - tricuspid valve, adult	10207-103F9	579.52	105.75	153.21	8.33	14.15	1.67	2.50	9.99
heart, adult, diseased post-infarction, donor1	10050-101G5	134.47	70.81	60.20	14.28	14.08	0.41	0.00	20.00
heart, adult, diseased, donor1	10051-101G6	129.45	15.76	20.44	6.81	10.22	0.00	0.00	4.26
heart, adult, pool1	10016-101C7	172.48	9.89	18.17	6.21	5.29	0.23	0.69	2.30
heart, fetal, pool1	10046-101G1	258.03	13.96	23.21	10.27	13.86	0.31	0.31	5.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	96.26	41.96	30.85	8.64	11.42	0.00	0.00	9.26
hepatoblastoma cell line:HuH-6	10633-108I3	296.10	77.30	41.62	16.65	16.65	1.19	1.19	27.35
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	248.73	165.85	93.81	24.20	32.82	0.22	0.22	32.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	235.34	150.14	84.35	26.34	31.19	0.36	0.36	29.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	239.40	155.93	85.19	24.25	27.89	0.20	0.20	32.13
hepatoma cell line:Li-7	10484-107A7	183.17	64.62	45.71	17.91	17.91	0.22	0.67	10.12
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	234.07	180.90	129.34	45.12	35.68	0.60	0.20	50.05
hippocampus - adult, donor10196	10169-103B7	227.12	83.28	75.71	8.52	6.62	0.00	1.89	13.25
hippocampus, adult, donor10252	10153-102I9	308.60	60.82	54.09	19.59	20.00	1.02	1.84	13.06
hippocampus, adult, donor10258	10374-105G5	80.17	8.96	31.87	6.97	2.99	0.00	0.00	8.96
hippocampus, newborn, donor10223	10363-105F3	243.56	65.56	86.00	6.70	9.87	0.35	0.70	13.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	667.72	151.98	195.92	30.52	23.80	0.00	0.00	25.63
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	596.53	128.42	137.25	21.80	19.64	0.00	0.00	22.78
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	617.22	130.25	152.85	20.82	19.80	0.51	1.02	20.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	465.75	47.93	59.77	23.12	17.48	0.00	0.56	26.50
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	462.20	63.52	56.29	20.92	13.17	0.26	0.52	21.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	419.47	40.62	47.45	14.05	19.36	0.00	0.38	15.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	333.70	32.99	35.03	11.09	7.88	0.88	0.88	9.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	398.33	46.96	46.96	11.42	6.03	0.65	0.65	14.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	357.43	42.54	50.47	7.09	8.76	0.00	0.42	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	224.95	32.20	37.89	15.15	15.15	0.24	0.00	10.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	338.95	57.38	58.34	16.55	11.57	0.16	0.16	13.98
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	246.43	30.97	50.50	8.08	10.77	0.00	0.00	10.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	568.66	149.91	141.15	23.16	20.19	0.47	0.47	24.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	531.09	128.72	139.53	17.69	18.18	0.00	0.49	24.07
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	939.08	171.06	196.37	25.31	13.96	0.00	0.00	22.69
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	448.83	51.16	44.29	21.57	17.56	0.00	0.00	19.28
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	401.19	37.07	37.94	22.68	14.39	0.00	0.44	21.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	362.83	45.98	38.98	20.49	12.99	0.00	0.50	16.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	298.04	43.52	41.26	13.75	13.19	0.19	0.75	16.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	366.50	41.38	47.29	14.10	4.09	0.00	0.45	18.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	330.78	37.28	51.68	10.96	9.71	0.00	1.57	14.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	216.86	41.32	41.32	15.19	11.10	0.00	0.16	12.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	202.06	40.35	43.55	10.45	9.87	0.00	0.00	11.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	231.96	42.75	60.68	11.36	9.57	0.00	1.49	13.15
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	494.19	126.92	119.35	30.67	24.20	0.00	0.37	24.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	451.32	117.25	127.24	20.26	18.54	0.00	0.00	19.68
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	559.39	150.67	170.27	31.85	26.54	0.00	0.82	24.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	317.58	33.80	46.12	14.79	10.56	0.00	0.35	10.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	370.59	47.19	47.83	15.20	10.45	0.00	0.00	14.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	305.04	39.04	40.25	13.92	9.68	0.00	0.00	13.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	203.75	27.41	37.23	8.79	5.69	0.00	1.03	13.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	247.73	23.91	29.22	7.31	6.64	0.00	0.66	9.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	150.07	21.55	30.01	9.49	10.26	0.00	0.77	7.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	174.10	36.81	36.30	10.48	8.69	0.26	0.00	8.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	226.41	33.32	43.16	12.87	9.84	0.00	0.00	17.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	206.68	51.75	50.41	9.41	9.41	0.00	0.00	8.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	467.31	129.93	110.13	24.39	23.67	0.00	0.24	22.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	538.36	121.22	150.63	20.50	33.42	0.00	1.34	25.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	521.47	132.20	145.37	23.41	17.56	0.00	0.98	31.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	317.23	36.37	32.40	15.28	9.78	0.31	0.31	12.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	416.42	42.29	42.29	84.58	22.77	0.00	3.25	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	328.96	34.75	32.10	12.58	9.60	0.00	0.33	14.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	279.12	31.20	39.41	11.49	5.47	0.00	0.55	10.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	247.89	23.52	31.48	10.13	7.60	0.36	0.36	12.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	251.96	26.69	35.23	6.41	6.05	0.00	0.71	13.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	331.76	34.61	41.77	8.35	11.93	0.00	1.19	9.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	236.86	37.24	42.52	11.51	12.87	0.00	0.27	9.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	217.13	41.76	44.72	12.93	11.58	0.27	0.27	9.43
immature langerhans cells, donor1	11904-125F5	84.02	64.90	37.77	9.20	7.02	0.24	0.00	7.26
immature langerhans cells, donor2	11905-125F6	109.31	73.67	32.48	5.54	7.92	0.00	2.38	7.13
insula, adult, pool1	10039-101F3	144.98	43.63	28.11	17.22	20.25	0.28	0.57	9.37
keratoacanthoma cell line:HKA-1	10791-110H8	122.26	57.88	47.15	12.03	9.75	0.00	0.65	13.66
kidney, adult, pool1	10017-101C8	209.37	41.05	34.44	8.61	8.51	0.10	0.00	7.11
kidney, fetal, pool1	10045-101F9	260.66	34.45	38.62	7.85	10.26	0.71	0.57	7.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	310.03	78.96	70.58	19.74	18.75	0.14	0.14	17.47
large cell lung carcinoma cell line:NCI-H460	10839-111E2	103.13	29.72	38.29	12.30	12.03	0.00	0.14	16.31
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	173.77	93.77	58.54	8.62	11.93	0.18	0.37	21.10
left atrium, adult, donor1	10079-102A7	123.14	17.98	21.79	5.45	11.99	0.54	0.00	6.54
left ventricle, adult, donor1	10078-102A6	214.90	27.81	41.97	9.61	10.11	0.00	0.00	11.63
leiomyoblastoma cell line:G-402	10721-110A1	154.32	121.76	85.37	18.06	18.33	0.82	0.00	27.09
leiomyoma cell line:10964C	10569-108B2	59.64	28.74	19.04	6.11	7.18	0.00	0.00	4.67
leiomyoma cell line:15242A	10570-108B3	60.87	36.41	22.83	5.43	3.26	0.00	0.00	3.80
leiomyoma cell line:15425	10571-108B4	90.33	44.92	29.62	12.14	7.77	0.00	0.00	7.28
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	31.75	19.05	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	128.60	95.15	47.05	12.55	13.59	0.00	0.00	18.82
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	149.93	118.53	93.74	18.18	20.42	0.47	0.12	20.42
liposarcoma cell line:KMLS-1	10782-110G8	76.23	29.21	21.87	7.81	4.53	0.00	0.31	9.22
liposarcoma cell line:SW 872	10726-110A6	84.43	49.83	31.68	20.71	20.35	0.12	0.00	19.62
liver, adult, pool1	10018-101C9	170.00	49.75	32.90	8.27	10.86	0.00	0.00	7.45
liver, fetal, pool1	10086-102B5	228.59	62.09	103.48	9.41	18.81	0.00	0.94	3.76
locus coeruleus - adult, donor10196	10182-103D2	276.34	85.45	83.70	13.71	11.37	0.29	0.58	13.12
locus coeruleus, adult, donor10252	10165-103B3	347.88	59.79	71.42	17.72	14.58	1.48	2.95	12.18
locus coeruleus, adult, donor10258	10375-105G6	190.16	47.96	71.95	11.85	8.75	0.00	0.00	10.72
locus coeruleus, newborn, donor10223	10362-105F2	573.72	80.76	112.73	7.57	7.15	0.84	0.42	8.41
lung adenocarcinoma cell line:A549	10499-107C4	131.20	35.71	35.43	11.49	7.61	0.00	0.14	13.01
lung adenocarcinoma cell line:PC-14	10408-106B3	153.74	49.64	38.61	4.83	11.03	0.69	0.00	12.41
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	116.66	88.19	36.91	28.60	25.44	0.00	0.40	33.88
lung, adult, pool1	10019-101D1	288.23	35.79	36.74	8.03	10.51	0.00	0.24	7.44
lung, fetal, donor1	10068-101I5	687.26	37.96	65.07	4.00	11.13	0.00	1.14	4.28
lung, right lower lobe, adult, donor1	10075-102A3	241.48	67.82	53.15	9.62	9.16	1.37	0.92	17.41
lymph node, adult, donor1	10077-102A5	192.19	53.02	55.86	13.25	12.31	0.47	0.47	18.46
lymphangiectasia cell line:DS-1	10727-110A7	154.08	44.49	39.45	14.03	14.25	0.22	0.00	14.90
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	387.43	155.61	84.67	48.60	52.37	0.60	0.45	28.07
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	86.65	47.57	43.32	9.34	4.25	0.00	1.70	4.25
mature adipocyte, donor1	12231-129F8	107.45	19.54	13.32	11.10	10.21	0.00	0.89	5.77
mature adipocyte, donor2	12232-129F9	126.38	18.68	13.70	8.92	9.55	0.00	0.00	5.19
mature adipocyte, donor3	12233-129G1	81.31	12.33	7.82	10.19	12.09	0.00	0.47	4.03
mature adipocyte, donor4	12234-129G2	143.98	20.27	16.06	11.32	12.11	0.26	0.53	7.90
maxillary sinus tumor cell line:HSQ-89	10414-106B9	249.46	76.00	57.66	19.30	17.63	0.24	1.43	20.25
medial frontal gyrus - adult, donor10196	10170-103B8	207.56	58.66	76.71	19.18	15.79	0.00	0.00	16.92
medial frontal gyrus, adult, donor10252	10150-102I6	285.05	63.82	57.38	24.09	25.20	1.10	1.29	17.29
medial frontal gyrus, adult, donor10258	10368-105F8	128.35	48.29	48.61	14.61	15.25	0.00	0.00	13.98
medial frontal gyrus, newborn, donor10223	10352-105E1	273.38	83.17	86.58	11.94	9.81	0.43	1.28	10.66
medial temporal gyrus - adult, donor10196	10183-103D3	234.39	99.39	85.22	20.08	19.91	0.00	0.34	17.38
medial temporal gyrus, adult, donor10252	10156-103A3	306.24	58.15	61.97	24.83	27.16	1.06	1.27	15.28
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	77.05	25.04	25.04	3.85	11.56	0.00	0.00	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	71.77	14.35	28.71	14.35	14.35	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	295.40	82.55	98.35	8.26	6.46	0.72	1.08	10.05
medulla oblongata - adult, donor10196	10174-103C3	252.45	31.80	63.60	7.14	7.14	0.65	0.00	3.89
medulla oblongata, adult, donor10252	10155-103A2	356.51	53.25	63.62	12.23	16.87	2.32	2.17	11.46
medulla oblongata, adult, pool1	10038-101F2	205.29	34.85	38.45	13.31	11.51	0.16	0.57	8.24
medulla oblongata, newborn, donor10223	10361-105F1	521.81	69.78	104.85	7.64	7.64	0.00	1.39	6.25
medulloblastoma cell line:D283 Med	10838-111E1	494.19	94.32	105.61	23.03	27.23	1.11	0.66	35.87
medulloblastoma cell line:ONS-76	10759-110E3	145.75	135.72	95.98	22.38	18.10	0.00	0.12	30.81
melanoma cell line:COLO 679	10514-107E1	122.04	34.64	26.31	7.91	6.04	0.14	0.29	8.48
melanoma cell line:G-361	10465-106H6	125.14	26.87	29.59	5.16	4.34	0.00	0.27	5.43
meningioma cell line:HKBMM	10691-109F7	150.15	51.92	31.48	12.66	9.77	0.00	0.00	7.06
merkel cell carcinoma cell line:MKL-1	10843-111E6	287.26	108.38	66.97	34.37	44.06	0.00	3.52	27.32
merkel cell carcinoma cell line:MS-1	10844-111E7	210.23	77.77	69.99	28.77	27.74	0.00	1.56	17.89
mesenchymal precursor cell - adipose, donor1	11747-123G1	94.52	49.71	32.99	13.66	12.74	0.00	0.00	9.36
mesenchymal precursor cell - adipose, donor2	11748-123G2	51.44	21.09	16.54	8.73	4.91	0.00	0.00	4.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	99.80	35.20	21.53	6.63	6.63	0.00	0.00	9.11
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.04	17.28	12.92	8.43	10.82	0.00	0.00	3.79
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.07	18.68	14.83	7.32	6.93	0.00	0.00	5.01
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	57.61	13.88	22.21	5.55	6.25	0.00	0.00	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	63.50	15.62	13.04	5.15	5.15	0.00	0.00	2.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	58.31	25.53	18.75	5.87	6.33	0.00	0.12	5.06
mesenchymal precursor cell - cardiac, donor3	11754-123G8	90.33	42.18	27.06	9.15	10.74	0.00	0.00	5.97
mesenchymal precursor cell - cardiac, donor4	11755-123G9	96.42	51.05	33.22	7.97	9.86	0.00	0.00	5.94
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	107.12	52.35	30.59	10.24	10.39	0.00	0.00	5.98
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	90.24	15.48	22.07	2.63	5.60	0.00	0.33	2.96
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	89.25	43.31	31.13	10.38	10.93	0.00	0.14	8.16
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	108.56	35.61	39.80	11.17	10.82	0.35	0.00	8.03
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	79.01	35.52	21.44	8.37	7.55	0.20	0.20	5.10
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	83.03	17.25	18.33	6.47	3.95	0.00	0.72	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	72.00	16.97	17.69	3.83	6.83	0.00	0.00	3.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	70.45	28.27	21.89	4.56	3.19	0.23	0.00	5.02
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	133.42	98.18	52.86	15.52	12.59	0.00	0.00	10.91
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	61.72	29.29	21.97	9.12	9.12	0.00	0.15	5.98
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	79.83	23.02	20.04	8.84	7.18	0.09	0.00	5.86
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	81.73	16.94	16.57	4.79	5.89	0.00	0.00	6.26
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	68.39	19.17	21.18	5.72	6.58	0.00	0.57	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	132.62	86.73	53.89	25.26	15.58	0.00	0.42	17.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	79.46	25.57	20.55	7.31	10.05	0.00	0.00	5.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	72.64	19.95	19.18	6.65	5.12	0.00	0.00	6.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	75.39	21.73	20.16	7.59	5.76	0.00	0.00	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	80.41	20.95	28.04	5.55	7.70	0.00	0.00	5.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	72.49	12.94	22.36	8.24	6.12	0.00	0.00	4.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	76.49	12.52	25.72	8.46	6.43	0.00	0.00	4.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	76.24	18.47	24.76	6.68	7.07	0.00	0.00	4.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	88.97	18.07	29.66	5.56	3.71	0.00	0.00	5.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	77.30	27.69	26.53	12.98	8.94	0.00	0.00	8.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	85.45	18.96	24.99	9.37	6.25	0.00	0.00	6.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	70.18	20.91	28.60	9.85	6.97	0.00	0.00	6.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	95.33	25.67	33.00	8.80	7.33	0.00	0.00	8.07
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	76.53	22.49	21.82	8.39	3.69	0.00	0.00	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	81.47	21.29	28.25	6.55	5.32	0.00	0.00	6.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	79.47	17.18	19.33	5.15	6.01	0.00	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	27.34	16.41	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	10.33	10.33	0.00	5.16	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	52.29	14.29	21.44	4.55	3.90	0.00	0.00	7.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	43.65	18.91	14.55	7.27	5.82	0.00	0.00	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	67.17	14.93	15.99	4.80	6.93	0.00	0.00	6.40
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	56.43	14.72	17.99	4.91	3.27	0.00	0.00	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	50.53	19.05	17.88	7.39	5.83	0.00	0.39	8.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	6.30	10.49	0.00	2.10	0.00	0.00	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	49.67	13.91	14.90	2.98	2.98	0.00	0.00	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	14.30	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	80.05	17.20	16.60	5.93	5.93	0.00	0.59	5.34
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	58.49	14.62	23.15	4.87	6.09	0.00	0.00	7.31
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	68.41	14.57	21.54	5.70	7.60	0.00	0.00	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	42.77	15.18	11.73	4.48	3.10	0.00	0.00	5.86
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	2.15	17.19	4.30	0.00	0.00	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	11.98	15.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	17.22	6.89	10.33	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	42.38	7.33	11.82	8.96	3.26	0.00	0.00	7.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	41.31	18.27	14.30	6.36	8.74	0.00	0.00	8.74
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	51.88	11.20	12.97	3.54	3.54	0.00	0.00	5.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	58.60	5.30	16.83	3.43	5.30	0.00	0.00	4.99
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	72.18	5.35	13.37	5.35	5.35	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	74.51	17.74	31.93	5.91	7.10	0.00	0.00	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	89.88	17.98	28.25	10.27	5.14	0.00	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	63.33	17.21	25.47	8.26	2.75	0.69	0.00	5.51
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	56.41	24.25	23.75	6.43	7.92	0.00	0.00	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	70.65	15.70	30.28	6.73	6.73	0.00	0.00	6.73
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	57.88	19.08	19.08	7.00	6.36	0.00	0.00	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	66.49	12.90	22.97	4.84	4.03	0.00	0.00	5.24
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	100.31	10.90	23.99	0.00	6.54	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	51.95	17.74	16.47	1.27	3.80	0.00	0.00	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	54.62	14.57	12.74	4.25	2.43	0.00	0.00	4.86
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	76.82	4.52	9.04	0.00	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	51.89	10.71	14.83	3.29	2.47	0.00	0.82	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.75	12.70	13.10	6.55	5.16	0.20	0.00	3.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	66.85	12.66	17.20	4.87	6.81	0.00	0.32	4.54
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	71.30	11.20	22.41	5.09	8.15	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	101.36	30.95	25.53	6.19	3.09	0.00	0.00	5.42
mesothelioma cell line:ACC-MESO-1	10493-107B7	238.84	68.51	55.99	9.69	8.27	0.24	0.47	9.45
mesothelioma cell line:ACC-MESO-4	10494-107B8	114.22	51.66	31.28	13.21	15.75	0.23	0.93	9.27
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	145.30	85.47	89.75	21.37	17.09	0.00	0.00	17.09
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	161.42	173.03	100.59	16.75	12.74	0.00	0.10	19.11
mesothelioma cell line:Mero-25	10850-111F4	133.68	87.15	62.64	31.55	27.01	0.00	0.00	27.23
mesothelioma cell line:Mero-41	10851-111F5	233.47	110.99	81.41	27.63	28.36	0.24	0.24	29.09
mesothelioma cell line:Mero-48a	10852-111F6	147.25	113.15	73.07	11.07	8.86	0.00	0.22	18.60
mesothelioma cell line:Mero-82	10853-111F7	139.29	77.26	60.97	12.61	17.61	0.00	0.26	18.92
mesothelioma cell line:Mero-83	10854-111F8	104.00	87.83	53.11	12.09	12.26	0.17	0.00	21.11
mesothelioma cell line:Mero-84	10855-111F9	153.94	86.20	64.96	12.39	12.64	0.25	0.25	14.66
mesothelioma cell line:Mero-95	10856-111G1	138.51	66.46	50.52	12.84	16.36	0.21	0.00	22.36
mesothelioma cell line:NCI-H2052	10847-111F1	249.13	120.92	87.46	16.56	23.69	0.00	0.66	24.52
mesothelioma cell line:NCI-H226	10846-111E9	189.86	156.38	102.98	29.68	24.07	0.00	0.36	41.27
mesothelioma cell line:NCI-H2452	10848-111F2	192.69	88.66	62.69	22.89	19.13	0.17	0.34	22.04
mesothelioma cell line:NCI-H28	10845-111E8	134.36	85.50	53.95	16.03	15.52	0.25	0.25	24.94
mesothelioma cell line:No36	10857-111G2	151.03	55.13	51.21	10.11	9.79	0.00	0.65	16.31
mesothelioma cell line:ONE58	10858-111G3	161.22	95.38	51.75	15.99	22.22	0.00	0.00	23.03
migratory langerhans cells, donor1	11901-125F2	154.88	46.06	45.29	11.52	10.75	0.96	0.77	8.44
migratory langerhans cells, donor2	11902-125F3	115.28	25.89	29.55	6.96	10.38	0.00	0.49	5.62
migratory langerhans cells, donor3	11903-125F4	106.25	21.90	27.64	5.20	8.26	0.00	0.54	3.95
mixed mullerian tumor cell line:HTMMT	10689-109F5	194.91	56.48	58.44	10.77	13.06	0.00	1.31	12.73
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	113.81	117.20	63.37	23.95	23.31	0.00	0.21	26.28
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	102.74	138.21	74.87	24.88	20.50	0.00	0.23	33.63
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	60.89	27.40	21.12	24.93	18.46	0.00	0.00	15.79
myelodysplastic syndrome cell line:SKM-1	10772-110F7	118.64	96.09	50.63	23.84	21.07	0.00	0.00	24.39
myeloma cell line:PCM6	10474-106I6	130.66	55.54	34.20	6.13	11.86	0.00	0.00	7.91
myxofibrosarcoma cell line:MFH-ino	10600-108E6	102.98	82.69	35.51	20.29	14.71	0.00	0.51	22.83
myxofibrosarcoma cell line:NMFH-1	10684-109E9	81.40	57.67	36.68	26.67	23.14	0.00	0.00	17.65
nasal epithelial cells, donor1, tech_rep1	12226-129F3	95.38	38.11	29.86	6.13	6.46	0.11	0.00	6.69
nasal epithelial cells, donor1, tech_rep2	12226-129F3	105.60	33.76	34.49	8.24	5.81	0.00	0.15	6.99
nasal epithelial cells, donor2	12227-129F4	73.41	26.50	27.05	7.73	7.18	0.00	0.00	2.76
neuroblastoma cell line:CHP-134	10508-107D4	231.21	37.04	52.68	27.15	29.91	0.46	1.38	17.48
neuroblastoma cell line:NB-1	10539-107G8	253.50	64.36	73.34	26.00	26.38	0.19	0.75	17.77
neuroblastoma cell line:NBsusSR	10607-108F4	412.08	113.46	97.01	49.14	48.72	0.84	0.84	33.74
neuroblastoma cell line:NH-12	10555-107I6	349.59	44.54	60.19	16.96	18.82	0.37	0.75	21.24
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	152.54	50.77	57.17	17.32	15.18	0.00	0.95	33.45
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	305.20	118.79	91.86	20.59	18.37	2.69	2.53	30.73
neuroectodermal tumor cell line:TASK1	10774-110F9	154.57	44.68	40.25	6.04	6.24	0.40	0.00	11.07
neuroepithelioma cell line:SK-N-MC	10728-110A8	164.03	138.60	92.82	35.60	26.07	0.00	0.00	38.15
neurofibroma cell line:Hs 53.T	10729-110A9	102.21	62.28	45.25	14.11	15.70	0.00	0.00	11.18
neutrophil PMN, donor1	12133-128D9	89.25	14.87	29.75	14.87	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	26.56	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	261.63	50.91	45.32	53.44	68.49	0.85	1.18	23.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	354.62	103.27	76.85	36.02	33.62	0.00	0.00	12.81
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	94.26	27.57	33.98	9.94	8.34	0.00	0.00	10.58
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	73.31	31.01	21.81	7.36	9.99	0.00	0.26	6.04
nucleus accumbens, adult, pool1	10037-101F1	161.23	33.75	32.25	17.72	18.09	0.00	0.47	9.09
occipital cortex - adult, donor10196	10172-103C1	226.64	61.81	70.05	14.42	22.66	0.00	0.00	14.42
occipital cortex, adult, donor10252	10163-103B1	373.29	62.80	65.48	26.03	27.91	1.61	1.07	15.03
occipital cortex, newborn, donor10223	10355-105E4	268.59	66.97	84.07	6.55	8.37	0.00	1.46	11.28
occipital lobe, adult, donor1	10076-102A4	191.29	57.73	51.43	18.11	16.01	0.26	0.52	14.43
occipital lobe, fetal, donor1	10073-102A1	368.60	83.25	133.88	27.89	20.60	0.00	0.43	31.75
occipital pole, adult, pool1	10036-101E9	122.84	26.49	21.84	17.11	19.71	0.16	0.00	9.46
olfactory region, adult	10195-103E6	165.83	48.72	38.21	17.39	19.11	0.19	0.19	13.76
optic nerve, donor1	10277-104E7	350.18	46.02	66.03	8.00	6.00	0.00	6.00	18.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	124.96	75.52	52.40	10.59	10.82	0.23	0.11	16.06
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	212.95	118.70	89.16	21.84	21.16	0.00	0.00	18.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	141.89	70.10	51.47	14.05	16.59	0.00	0.00	12.87
oral squamous cell carcinoma cell line:SAS	10544-107H4	119.90	45.74	40.54	15.94	10.40	0.00	0.23	15.48
osteoclastoma cell line:Hs 706.T	10704-109H2	95.83	57.32	31.16	9.99	13.52	0.00	0.00	10.58
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	128.00	58.86	26.16	15.88	15.88	0.00	0.00	11.21
osteosarcoma cell line:HS-Os-1	10558-107I9	150.99	46.87	44.53	10.39	12.51	0.21	0.64	7.42
ovary, adult, pool1	10020-101D2	336.13	37.56	39.92	11.01	10.39	0.00	0.00	13.80
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	116.96	110.91	73.14	19.43	16.32	0.00	0.18	29.15
pancreas, adult, donor1	10049-101G4	192.83	54.56	58.32	13.17	11.29	0.94	0.00	25.40
pancreatic carcinoma cell line:NOR-P1	10698-109G5	279.26	118.52	90.29	22.92	15.65	0.00	0.56	42.49
papillary adenocarcinoma cell line:8505C	10437-106E5	131.34	66.10	41.91	11.24	14.14	0.17	0.00	12.10
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	149.36	58.95	39.74	15.73	14.07	0.33	0.33	10.76
paracentral gyrus, adult, pool1	10035-101E8	139.11	33.86	29.38	17.66	17.30	0.18	0.46	9.06
parietal cortex, adult, donor10258	10373-105G4	120.38	11.74	44.04	12.48	8.07	0.00	0.00	5.14
parietal lobe - adult, donor10196	10171-103B9	221.01	54.55	67.71	12.23	11.29	0.00	0.00	16.93
parietal lobe, adult, donor10252	10157-103A4	275.63	56.15	59.86	25.08	24.80	1.71	1.71	16.25
parietal lobe, adult, pool1	10034-101E7	148.75	36.04	28.29	21.50	19.21	0.18	0.53	7.84
parietal lobe, fetal, donor1	10072-101I9	421.88	89.22	134.81	19.40	26.19	0.00	0.00	28.13
parietal lobe, newborn, donor10223	10356-105E5	342.08	85.24	108.42	9.72	8.97	0.00	0.75	13.09
parotid gland, adult	10199-103F1	136.90	23.43	27.13	8.02	16.03	0.62	0.00	8.02
penis, adult	10200-103F2	172.41	23.10	24.17	9.67	13.43	0.00	1.07	10.21
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	337.85	115.65	78.28	21.01	15.25	0.93	2.23	20.82
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	230.63	123.99	94.26	32.49	24.62	0.00	0.44	29.72
pineal gland - adult, donor10196	10179-103C8	170.93	36.12	61.28	13.55	16.77	0.65	0.65	6.45
pineal gland, adult, donor10252	10160-103A7	284.26	33.76	46.78	13.62	16.58	1.78	0.00	10.66
pineal gland, adult, donor10258	10377-105G8	140.46	22.57	43.90	6.90	10.66	0.00	1.25	13.80
pituitary gland - adult, donor10196	10180-103C9	358.18	27.32	67.79	7.08	9.11	0.00	3.04	8.09
pituitary gland, adult, donor10252	10162-103A9	548.28	41.69	84.95	8.34	13.55	1.04	0.52	6.78
pituitary gland, adult, donor10258	10378-105G9	366.03	35.75	73.21	8.51	15.32	0.85	0.00	11.07
placenta, adult, pool1	10021-101D3	199.20	25.91	28.06	6.24	5.38	0.00	0.22	5.38
plasma cell leukemia cell line:ARH-77	10840-111E3	133.22	50.59	44.89	18.94	19.60	0.13	0.13	13.38
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	112.99	41.87	36.89	9.81	11.52	0.00	0.31	5.91
pons, adult, pool1	10033-101E6	132.03	39.50	32.45	14.63	14.98	0.77	0.34	8.26
postcentral gyrus, adult, pool1	10032-101E5	126.49	35.83	27.29	19.27	16.13	0.17	0.00	10.72
promyelocytes/myelocytes PMC, donor1	12132-128D8	242.60	167.31	83.66	58.56	23.01	0.00	0.00	27.19
promyelocytes/myelocytes PMC, donor2	12136-128E3	110.16	22.03	27.54	5.51	5.51	0.00	0.00	16.52
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	46.94	82.15	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	240.63	127.89	71.08	27.97	19.96	0.58	0.44	20.10
prostate cancer cell line:PC-3	10439-106E7	213.45	88.39	64.25	29.95	23.23	0.18	0.54	16.88
prostate, adult, pool1	10022-101D4	357.23	26.03	33.01	8.80	8.98	0.45	0.54	8.80
putamen, adult, donor10196	10176-103C5	192.63	68.93	52.88	24.55	17.47	0.47	0.24	22.19
putamen, adult, donor10252	10152-102I8	194.11	41.18	45.10	9.80	7.84	0.00	1.96	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	207.63	37.16	41.53	10.93	7.65	0.00	0.00	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	98.34	28.99	32.38	11.11	13.53	0.24	0.72	12.56
putamen, newborn, donor10223	10365-105F5	773.65	86.96	161.93	6.00	6.75	0.00	0.00	5.25
rectal cancer cell line:TT1TKB	10469-106I1	124.81	38.40	25.31	7.27	8.73	0.00	0.00	9.89
rectum, fetal, donor1	10067-101I4	280.98	63.99	54.25	15.30	12.52	1.39	2.78	27.82
renal cell carcinoma cell line:OS-RC-2	10411-106B6	117.24	59.15	25.02	18.02	16.75	0.21	0.42	11.45
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	173.97	44.32	27.34	17.81	14.08	0.00	1.66	15.33
retina, adult, pool1	10030-101E3	154.47	18.19	18.19	10.14	8.75	0.20	0.10	6.66
retinoblastoma cell line:Y79	10475-106I7	205.24	75.86	47.28	30.40	35.07	0.52	0.78	25.98
rhabdomyosarcoma cell line:KYM-1	10787-110H4	188.85	80.65	56.68	15.74	12.79	0.25	0.25	11.68
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	657.73	43.30	52.58	14.62	22.21	1.12	0.56	11.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.79	15.91	12.13	12.88	12.13	0.00	0.00	6.82
salivary acinar cells, donor1	11771-123I7	80.12	30.27	28.16	7.93	8.90	0.16	0.00	15.38
salivary acinar cells, donor2	11772-123I8	62.65	25.75	27.81	10.88	11.98	0.00	0.14	13.63
salivary acinar cells, donor3	11773-123I9	72.83	26.48	33.76	5.96	11.92	0.00	1.32	15.89
salivary gland, adult, pool1	10093-102C3	186.46	20.02	14.87	5.15	7.44	0.00	0.00	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	118.88	71.75	39.71	24.87	24.03	0.17	0.25	21.92
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	101.56	68.77	40.67	26.68	23.98	0.12	0.12	19.98
seminal vesicle, adult	10201-103F3	264.54	29.63	32.80	10.05	8.47	1.59	2.65	8.99
serous adenocarcinoma cell line:JHOS-2	10639-108I9	133.37	73.85	49.80	9.47	10.45	0.24	0.73	11.90
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	156.52	34.73	35.98	6.04	7.30	0.00	0.00	7.80
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	331.17	85.30	83.29	19.07	15.05	0.00	0.00	9.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	285.43	95.90	66.76	9.67	9.13	0.13	1.34	19.48
signet ring carcinoma cell line:Kato III	10436-106E4	73.50	104.34	37.69	21.88	20.12	0.00	0.44	22.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	241.28	105.80	67.87	21.16	22.58	0.26	0.13	26.58
skeletal muscle - soleus muscle, donor1	10282-104F3	128.39	26.25	13.48	7.80	9.22	0.00	0.71	9.22
skeletal muscle, adult, pool1	10023-101D5	208.57	24.11	27.71	6.84	11.87	0.12	0.00	6.84
skeletal muscle, fetal, donor1	10066-101I3	222.11	30.15	50.25	5.03	9.05	0.00	0.00	7.04
skin, adult, donor1	10074-102A2	278.19	54.28	47.50	6.79	13.57	0.00	0.00	40.71
skin, fetal, donor1	10065-101I2	152.13	40.40	34.09	8.84	11.36	0.63	0.63	8.21
small cell cervical cancer cell line:HCSC-1	10800-110I8	281.83	47.69	50.03	31.68	24.35	0.67	0.00	14.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	254.69	46.34	62.10	8.83	9.14	0.00	0.32	9.77
small cell lung carcinoma cell line:DMS 144	10841-111E4	217.80	64.57	69.20	21.01	17.54	0.19	0.00	23.32
small cell lung carcinoma cell line:LK-2	10541-107H1	386.35	85.87	72.19	41.54	31.65	0.49	0.33	23.90
small cell lung carcinoma cell line:NCI-H82	10842-111E5	657.88	79.62	114.20	17.85	12.39	0.48	0.64	32.33
small cell lung carcinoma cell line:WA-hT	10562-108A4	371.11	76.05	75.40	22.01	27.89	0.00	0.65	20.48
small intestine, adult, pool1	10024-101D6	161.96	56.74	35.12	15.65	18.63	0.48	0.48	13.74
small intestine, fetal, donor1	10064-101I1	168.06	83.29	59.21	15.97	19.90	0.25	0.74	28.50
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	180.54	74.37	36.42	15.90	11.80	0.00	1.54	9.75
smooth muscle, adult, pool1	10048-101G3	302.65	26.62	38.77	10.34	9.30	1.03	1.29	9.56
somatostatinoma cell line:QGP-1	10781-110G7	199.41	88.71	87.11	16.35	14.21	0.27	0.00	23.32
spinal cord - adult, donor10196	10181-103D1	334.47	85.11	90.16	13.99	14.68	0.00	0.69	13.53
spinal cord, adult, donor10252	10159-103A6	443.16	45.34	61.11	7.10	11.43	1.58	0.79	5.52
spinal cord, adult, donor10258	10369-105F9	196.47	7.61	58.11	6.23	2.77	0.00	0.69	9.69
spinal cord, fetal, donor1	10056-101H2	191.49	41.47	43.91	15.25	15.25	0.00	0.00	7.32
spinal cord, newborn, donor10223	10359-105E8	449.11	83.12	118.02	7.35	7.35	0.00	1.84	6.89
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	93.79	58.55	43.01	17.47	9.71	0.15	0.00	10.01
spleen, adult, pool1	10025-101D7	200.44	33.15	30.40	10.02	11.45	0.11	0.44	5.40
spleen, fetal, pool1	10044-101F8	220.49	22.57	38.54	7.71	10.89	0.48	0.56	5.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	164.27	96.78	59.93	26.81	25.67	0.31	0.62	17.80
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	166.90	47.28	35.70	12.34	11.96	0.00	0.38	8.73
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	180.32	109.03	92.60	17.47	16.77	0.35	0.70	22.71
squamous cell carcinoma cell line:T3M-5	10616-108G4	136.83	108.68	57.08	5.86	12.51	0.00	0.00	18.76
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	121.45	100.97	47.39	16.32	21.61	0.23	0.34	15.53
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	344.39	99.12	104.63	14.83	17.37	0.42	0.00	18.64
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	143.84	63.04	55.00	15.65	15.23	0.00	0.42	12.27
stomach, fetal, donor1	10062-101H8	64.08	39.52	16.02	16.02	12.82	0.00	0.00	22.43
submaxillary gland, adult	10202-103F4	157.80	22.22	20.51	5.13	7.41	0.00	0.57	5.13
substantia nigra - adult, donor10196	10178-103C7	434.19	54.27	162.82	0.00	0.00	54.27	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	424.34	58.37	68.75	16.41	19.11	2.49	4.98	9.35
substantia nigra, adult, donor10258	10371-105G2	135.52	4.14	52.24	6.72	5.69	0.00	0.00	9.31
substantia nigra, newborn, donor10223	10358-105E7	695.98	72.07	117.29	2.83	7.77	0.00	0.71	8.48
synovial sarcoma cell line:HS-SY-II	10441-106E9	240.73	91.94	60.30	31.41	29.12	0.46	0.69	22.01
temporal lobe, adult, pool1	10031-101E4	119.36	36.71	29.50	15.60	15.77	0.08	0.08	10.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	290.61	44.87	103.28	15.67	14.25	0.00	0.71	10.68
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	236.03	28.57	58.46	14.07	11.87	0.00	0.00	6.15
tenocyte, donor1	11763-123H8	113.46	28.98	27.93	8.38	5.24	0.00	0.35	6.63
tenocyte, donor2	11765-123I1	87.75	18.69	17.55	5.72	5.72	0.00	0.00	4.20
tenocyte, donor3	11768-123I4	90.81	27.06	31.88	10.01	9.27	0.00	0.00	4.45
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	525.01	201.40	178.97	30.25	30.76	0.17	1.02	36.54
teratocarcinoma cell line:NCR-G1	10798-110I6	364.41	54.88	61.35	13.26	14.34	0.15	0.15	17.42
teratocarcinoma cell line:PA-1	10807-111A6	360.48	76.71	76.56	20.30	15.50	0.15	0.31	22.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	390.36	117.93	91.15	43.80	21.83	0.63	0.76	40.88
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	616.80	94.16	121.02	12.48	9.08	1.51	0.38	31.77
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	252.59	35.23	34.14	6.22	5.34	0.22	0.44	9.92
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	712.64	93.15	109.44	16.61	9.77	0.33	0.65	25.73
testis, adult, pool1	10026-101D8	169.54	37.04	23.30	18.79	17.07	0.32	0.32	11.81
testis, adult, pool2	10096-102C6	150.66	49.17	31.12	37.89	36.99	0.00	0.45	29.77
thalamus - adult, donor10196	10168-103B6	323.47	52.99	73.97	7.73	6.62	0.00	2.21	16.56
thalamus, adult, donor10252	10154-103A1	454.47	51.57	65.48	14.22	18.13	2.19	2.03	12.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	204.77	13.86	18.48	7.70	6.16	0.00	0.00	15.40
thalamus, adult, donor10258, tech_rep2	10370-105G1	161.07	52.21	52.87	15.15	12.35	0.00	0.66	16.30
thalamus, newborn, donor10223	10366-105F6	344.62	86.87	96.65	9.21	4.60	0.00	0.58	6.33
throat, adult	10209-103G2	115.85	30.21	22.22	9.24	8.49	0.25	0.75	8.24
throat, fetal, donor1	10061-101H7	179.78	53.32	47.53	11.58	15.84	0.00	1.22	15.24
thymic carcinoma cell line:Ty-82	10803-111A2	341.02	147.06	118.64	25.44	27.62	0.60	0.60	29.41
thymus, adult, pool1	10027-101D9	253.11	45.33	48.61	21.08	26.44	0.30	0.20	13.62
thymus, fetal, pool1	10043-101F7	277.32	47.17	49.77	16.73	18.29	1.87	1.04	9.87
thyroid carcinoma cell line:KHM-5M	10776-110G2	250.10	110.62	90.28	22.74	23.00	0.00	0.00	23.00
thyroid carcinoma cell line:TCO-1	10783-110G9	122.79	61.18	45.68	14.39	13.97	0.00	0.28	21.65
thyroid, adult, pool1	10028-101E1	451.45	43.20	53.28	9.89	15.49	0.47	0.47	11.48
thyroid, fetal, donor1	10060-101H6	218.05	44.03	59.32	12.13	13.71	0.53	1.05	13.45
tongue epidermis (fungiform papillae), donor1	10288-104F9	160.14	40.04	18.48	15.40	18.48	0.00	0.00	3.08
tongue, adult	10203-103F5	125.59	43.26	27.68	13.02	11.16	0.47	0.23	8.37
tongue, fetal, donor1	10059-101H5	216.75	43.35	45.32	11.82	15.76	0.79	0.79	15.37
tonsil, adult, pool1	10047-101G2	162.69	37.57	31.05	14.02	13.72	0.40	0.30	9.12
trachea, adult, pool1	10029-101E2	219.06	49.00	43.44	10.80	12.92	0.08	0.49	9.90
trachea, fetal, donor1	10058-101H4	194.66	44.24	52.70	10.00	13.85	0.38	0.77	12.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	125.41	92.47	55.98	14.88	7.79	0.00	0.35	14.53
transitional-cell carcinoma cell line:5637	10418-106C4	94.22	57.14	32.32	15.81	15.10	0.10	0.20	9.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	272.01	52.33	58.76	14.42	14.73	0.63	0.94	13.95
tridermal teratoma cell line:HGRT	10694-109G1	104.64	47.56	45.66	28.54	17.12	0.00	0.00	15.22
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	404.97	144.50	131.55	23.96	20.49	0.25	0.34	41.73
umbilical cord, fetal, donor1	10057-101H3	129.36	37.56	54.25	12.52	8.35	2.09	0.00	18.78
uterus, adult, pool1	10100-102D1	431.69	32.42	33.61	6.83	13.14	0.34	1.19	8.36
uterus, fetal, donor1	10055-101H1	229.86	51.70	51.19	17.92	11.26	0.00	0.00	15.87
vagina, adult	10204-103F6	1684.64	233.92	266.88	13.57	21.97	1.94	1.29	23.91
vein, adult	10191-103E2	216.57	36.83	42.52	9.21	10.52	0.22	0.66	7.89
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.36	30.71	27.77	10.15	10.95	0.00	0.53	13.08